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1.INTRODUCTION 
Cancer results from different molecular events that changes  the normal  
fundamental properties of cells. In cancer cells the normal systems prevent cell 
overgrowth and the invasion of other tissues are disabled. These altered cells grow  and 
divide  in the presence of signals that n inhibit cell growth normally . As these cells 
grow they develop new characteristics, including changes in cell structure, decreased 
cell adhesion, and production of new enzymes. These changes allow the cell and its 
progeny to grow and divide, even in the presence of normal cells that  inhibit the growth 
of nearby cells. This changes allow the cancer cells to spread and invade other tissue 
cells.  Abnormalities in cancer cells  result from mutations in protein-encoding genes 
that regulate cell division. This process  is often because the genes that make the 
proteins that normally repair DNA damage are themselves not functioning normally and  
they are also mutated.Mutations begin to increase in the cell, causing further abnormal 
changes  in that cell and the daughter cells. Some of these mutated cells die,  other 
alterations may give the abnormal cell a selective advantage that allows it to multiply 
more rapidly than the normal cells. This type of  enhanced growth describes most cancer 
cells, which have improved  functions present  in the normal, healthy cells. As long as 
these cells remain in their original place, they are known as  benign; if they become 
invasive, they are known as  malignant.  
Genetics of Cancer  
Thirty five thousands genes in the human genome had been associated with 
cancer.  Alterations in the same gene often are associated with different types of cancer. 
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This malfunctioning genes can be classified into three groups. The first group, called 
proto-oncogenes, produces protein products that normally enhance cell division or 
inhibit normal cell death and the mutated form is known as  oncogenes. The second 
group is known as  tumor suppressors,which  makes proteins that normally prevent cell 
division or cause cell death. The third group is  DNA repair genes, which help prevent 
mutations that lead to cancer. Cell growth control is maintained by regulation of proto-
oncogenes, which accelerate growth, and tumor suppressor genes and slow cell growth. 
Mutations  produce oncogenes enhance growth while those that affect tumor suppressor 
genes  prevent the normal inhibition of growth. In both case, uncontrolled cell growth 
occurs. 1,2 
Oncogenes  
In normal cells, proto-oncogenes code for the proteins that send a signal to the 
nucleus to stimulate cell division. These signaling proteins act in a series of steps called 
signal transduction cascade or pathway. This cascade includes a membrane receptor for 
the signal molecule, intermediary proteins that carry the signal through the cytoplasm. 
The transcription factors in the nucleus that activate the genes for cell division. 
Oncogenes are altered versions of the proto-oncogenes that code for these signaling 
molecules. The oncogenes activate the signaling cascade continuously, resulting in an 
increased production of factors that stimulate growth.MYC is a proto-oncogene that 
codes for a transcription factor. Mutations in MYC convert it into an oncogene 
associated with seventy percent of cancers. RAS is another type of  oncogene that 
normally functions as an “on-off” switch in the signal cascade. Mutations in RAS cause 
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the signaling pathway to remain “on,” leading to uncontrolled cell growth. About thirty 
percent of tumors such as  lung, breast, colon, thyroid, and pancreatic carcinomas have a 
mutation in RAS.3,4 
The conversion of a proto-oncogene to an oncogene occur by mutation of the 
proto-oncogene, by rearrangement of genes in the chromosome which  moves the proto-
oncogene to a new location, or by an increase in the number of copies of the normal 
proto-oncogene.  A virus inserts its DNA in or near the proto-oncogene, causing it to 
become an oncogene. The result of any of these events is an altered form of the gene, 
which leads to cancer. Most of the  oncogenes are dominant mutations; a single copy of 
this gene is sufficient for expression of the growth trait. This is also a “gain of function” 
mutation because the cells with the mutant form of the protein have gained a new 
function not present in cells with the normal gene 5,6  
 Biology of Tumour 
Cancer cells behave as independent cells, growing without control to form 
tumors. Tumors grow in a series of steps. The first step is hyperplasia, defining that 
there are more no of  cells resulting from uncontrolled cell division. These cells appear 
normal, but changes have occurred that result in loss of control of growth. The second 
one  is dysplasia, resulting from further growth, accompanied by abnormal changes to 
the cells. The third one requires additional changes, which result in cells that are more 
abnormal and  now spread over a wider area of tissue. These cells begin to lose their 
original function; such cells are known as  anaplastic. At this stage, because the tumor is 
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still present  within its original location (called in situ) and is not invasive, it is not 
considered malignant — it is potentially malignant. The last step occurs when the cells 
in the tumor metastasize, which means that they can invade surrounding tissue, 
including the bloodstream, and spread to other locations. This is the most serious type of 
tumor, but not all tumors progress to this point. Non-invasive tumors are said to be 
benign.  
The type of tumor that produces depends on the type of cell that was initially 
altered. There are five types of tumors 7,8  
• Carcinomas produced from altered epithelial cells, which cover the surface of 
the skin and internal organs. Most cancers are carcinomas. 
 • Sarcomas produced from changes in muscle, bone, fat, or connective tissue. 
 • Leukemia rproduced  from malignant white blood cells.  
• Lymphoma is a cancer of the lymphatic system cells that occour from bone 
marrow.  
• Myelomas are cancers of specialized white blood cells that produce antibodies. 
Although tumor cells are no longer dependent on the control mechanisms that 
govern normal cells, they still require nutrients and oxygen in order to grow. All living 
tissues are supplied with capillary vessels, which bring nutrients and oxygen to all cell. 
As tumors enlarge, the cells in the center and cannot  receive nutrients from the normal 
blood vessels. To give  a blood supply for all the cells in the tumor, it should  form new 
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blood vessels to supply the cells in the center with nutrients and oxygen. In the pocess of  
angiogenesis, tumor cells produce growth factors and induce formation of new capillary 
blood vessels. The blood vessels  cells that divide to produce  new capillary vessels are 
inactive in normal tissue and tumors make angiogenic factors, which activate the  blood 
vessel cells to divide. Without a blood supply, tumor cells also cannot spread and  
metastasize, to new tissues. The tumor cells can cross through the walls of the capillary 
of blood vessel at a rate of about one million cells per day.  Not all cells in a tumor are 
angiogenic. Both angiogenic and nonangiogenic cells in a tumor cross into blood vessels 
and spread and  non-angiogenic cells give rise to dormant tumors when they grow in  
other areas 9,10. Oncogene called BCL2 has been shown to greatly increase the 
production of a potent stimulator of angiogenesis. It appears, then, that oncogenes in 
tumor cells may cause an increased expression of genes that make angiogenic factors. 
There are at least fifteen angiogenic factors and production of many of these is increased 
by a variety of oncogenes. Therefore, oncogenes in some tumor cells allow those cells to 
produce angiogenic factors. The progeny of these tumor cells will also produce 
angiogenic factors, so the population of angiogenic cells will increase as the size of the 
tumor increases. Dormant tumors are those that do not have blood vessels; they are 
generally less than half a millimeter in diameter. Several autopsy studies in which 
trauma victims were examined for such very small tumors revealed that thirtynine 
percent of women aged above 40  have very small breast tumors, while 60  percent of 
men aged above 60  have very small prostate tumors. 90 percent of people aged above 
50  have very small thyroid tumors. However, for those age groups in the general 
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population, the incidence of these particular cancers is only one-tenth of a percent 
(thyroid) or one percent (breast or prostate cancer). The conclusion is that the incidence 
of dormant tumors is high compared to the incidence of cancer. So that angiogenesis is 
critical for the progression of dormant tumors into cancer.11 
Traditional Treatment 12 
Cancer comprises many diseases, doctors use many different treatments. The 
course of treatment depends on the type of cancer, its location, and its state of 
advancement. Surgery is the first treatment option, which is used to remove solid tumors 
and only treatment necessary for early stage cancers and benign tumors. Radiation kills 
cancer cells targeted directly to the tumor. And acts  primarily by damaging DNA and 
inhibiting  its replication; so that , it kills cancer cells, which rapidly divide. It also kills 
some normal cells, particularly those that are dividing. Surgery and radiation treatment 
are often used together. Chemotherapy drugs are toxic compounds that kills rapidly 
growing cells. Many of these drugs are designed to interfere with the synthesis of 
precursor molecules needed for DNA replication mechanis and  interfere with the 
activity  of the cell to complete the S phase of the cell cycle. 
Modern  Treatments 13 
Many of the factors that affect normal cell growth are hormones. Although 
cancer cells have lost some of the normal responses to growth factors, some cancer cells 
still require hormones for growth. Hormone therapy for cancer attempts to starve the 
cancer cells of these hormones. This is usually done with drugs that block the activity of 
the hormone, although some drugs can block synthesis of the hormone. For example, 
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some breast cancer cells require estrogen for growth. Drugs that block the binding site 
for estrogen can slow the growth of these cancers. These drugs are called selective 
estrogen receptor modulators (SERMs) or anti-estrogens. Tamoxifen and Raloxifene are 
examples of this type of drug. A ten-year clinical trial of these two drugs with 20,000 
women began in 1999 to determine their effectiveness in preventing breast cancer. 
Similarly, testosterone (an androgen hormone) stimulates some prostate cancer cells. 
Selective androgen receptor modulators (SARMs) are drugs that block the binding of 
testosterone to these cancer cells, inhibiting their growth and possibly preventing 
prostate cancer. Newer chemotherapeutic drugs target specific, active proteins or 
processes in cancer cell signal transduction pathways, such as receptors, growth factors, 
or kinases . Because the targets are cancer-specific proteins, the hope is that these drugs 
will be much less toxic to normal cells than conventional cancer drugs. The oncogene 
RAS is mutated in many types of cancer, particularly pancreatic cancer, which has a 
poor rate of survival for those afflicted. The RAS protein is only active after it is 
modified by the addition of a specific chemical group. Scientists are developing drugs to 
inhibit the action of the enzyme that adds the chemical group to the RAS protein, 
resulting in an inactive form of RAS. Early tests indicate that these drugs show promise 
for reducing tumors in cancer patients. Chemotherapy may fail because the cancer cells 
become resistant to the therapeutic drugs. One of the characteristics of cancer cells is a 
high frequency of mutation. In the presence of toxic drugs, cancer cells that mutate and 
become resistant to the drug will survive and multiply in the presence of the drug, 
producing a tumor that is also resistant to the drug. To overcome this problem, 
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combinations of chemotherapy drugs are given at the same time.14 This decreases the 
probability that a cell will develop resistance to several drugs at once; however, such 
multiple resistances do occur. Some drug-resistant cancer cells express a gene called 
MDR1 (multiple drug resistance). This gene encodes a membrane protein that can not 
only prevent some drugs from entering the cell, but can also expel drugs already in the 
cell. Some cancer cells make large amounts of this protein, allowing them to keep 
chemotherapy drugs outside the cell. Another promising target for cancer therapy is 
angiogenesis. Several drugs, including some naturally occurring compounds, have the 
ability to inhibit angiogenesis. Two compounds in this class are angiostatin and 
endostatin; both are derived from naturally occurring proteins. These drugs prevent 
angiogenesis by tumor cells, restricting tumor growth and preventing metastasis. One 
important advantage of angiogenesis inhibitors is that, because they do not target the 
cancer cells directly, there is less chance that the cancer cells will develop resistance to 
the drug. One contributing factor in cancer is the failure of the immune system to 
destroy cancer cells. Immunotherapy encompasses several techniques that use the 
immune system to attack cancer cells or treat the side effects of some types of cancer 
treatment. The least specific of these are the immunostimulants, such as interleukin 2 
and alpha interferon, which enhance the normal immune response. A technique called 
chemoimmunotherapy attaches chemotherapy drugs to antibodies that are specific for 
cancer cells. The antibody then delivers the drug directly to cancer cells without 
harming normal cells, reducing the toxic side effects of chemotherapy. These molecules 
contain two parts: the cancer-cell-specific antibody and a drug that is toxic once it is 
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taken into the cancer cell. A similar strategy, radioimmunotherapy, couples specific 
antibodies to radioactive atoms, thereby targeting the deadly radiation specifically to 
cancer cells. Another immunological approach uses antibodies that inactivate cancer-
specific proteins, such as growth factors or tumor cell receptors, which are required by 
tumor cells. For example, many breast and ovarian cancer cells over-express a receptor 
protein called HER2. An antibody called Herceptin, which binds HER2, inhibits tumor 
growth by preventing the binding of growth factors to these cells. Some cancers, 
particularly leukemia, are treated with very high doses of chemotherapy drugs and 
radiation intended to kill all the cancer cells.15 The side effect of this harsh treatment is 
destruction of the bone marrow, which contains stem cells. Stem cells, immature cells 
that develop into blood cells, are essential. After treatment, the patient’s bone marrow 
must be restored, either from bone marrow removed from the patient before drug 
therapy or from a compatible donor. Although the patient’s own bone marrow is best, it 
can contain cancer cells that must be destroyed before it is returned to the patient  
Preventing Cancer  
Cancer appears to result from a combination of genetic changes and 
environmental factors. A change in lifestyle that minimizes exposure to environmental 
carcinogens is one effective means of preventing cancer. Individuals who restrict their 
exposure to tobacco products, sunlight, and pollution can greatly decrease their risk of 
developing cancer. Many foods contain antioxidants and other nutrients that may help to 
prevent cancer. The National Cancer Institute recommends a diet with large amounts of 
colorful fruits and vegetables. These foods supply ample amounts of vitamin A, C, and 
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E, as well as phytochemicals and other antioxidants that help to prevent cancer. There is 
strong evidence that a diet rich in vegetables and fruits will not only reduce the risk of 
cardiovascular disease, obesity, and diabetes, but will also protect against cancer.16 
Vaccines also offer some promise for prevention of cancer. The first vaccine to prevent 
cancer was for hepatitis B, which is associated with liver cancer. An effective hepatitis 
B vaccine is available that can prevent both hepatitis and the cancer that may follow this 
infection. In 2002, test results of a papillomavirus vaccine were reported. Human 
papillomavirus type 16 infects about twenty percent of adults. Although most 
papillomavirus infections do not cause cancer, some are associated with cervical cancer. 
A vaccine against this virus was administered to 1,200 young women in the United 
States. Within eighteen months, the vaccine produced high levels of antibodies to the 
virus, and prevented both papillomavirus infection and precancerous lesions in all the 
women. In the control group of about 1,200 women who did not receive the vaccine, 
forty-one infections and nine precancerous lesions were found. The vaccine can also 
prevent genita warts caused by this virus strain. It appears that vaccines such as these 
may help in the fight to prevent cancers associated with viruses17 
BREAST CANCER 
Breast cancer is a  type of malignant tumour that derived from the  cells of the 
breast.  Malignant tumour is a group of cancer cells that can grow into (invade) 
surrounding tissues or spread (metastasize) to distant areas of the body. The disease 
occurs almost entirely in women, but men can get it, too. The female breast is made up 
mainly of lobules (milk-producing glands), ducts (tiny tubes that carry the milk from the 
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lobules to the nipple), and stroma (fatty tissue and connective tissue surrounding the 
ducts and lobules, blood vessels, and lymphatic vessels). Most breast cancers begin in 
the cells that line the ducts (ductal cancers). Some begin in the cells that line the lobules 
(lobular cancers), while a small number start in other tissues. The lymph system is 
important to understand because it is one way breast cancers can spread. This system 
has several parts. Lymph nodes are small, bean-shaped collections of immune system 
cells (cells that are important in fighting infections) that are connected by lymphatic 
vessels. Lymphatic vessels are like small veins, except that they carry a clear fluid called 
lymph (instead of blood) away from the breast 18 Lymph contains tissue fluid and waste 
products, as well as immune system cells. Breast cancer cells can enter lymphatic 
vessels and begin to grow in lymph nodes. Most lymphatic vessels in the breast connect 
to lymph nodes under the arm (axillary nodes). Some lymphatic vessels connect to 
lymph nodes inside the chest (internal mammary nodes) and either above or below the 
collarbone (supraclavicular or infra clavicular nodes). If the cancer cells have spread to 
lymph nodes, there is a higher chance that the cells could have also gotten into the 
bloodstream and spread (metastasized) to other sites in the body. The more lymph nodes 
with breast cancer cells, the more likely it is that the cancer may be found in other 
organs as well. Because of this, finding cancer in one or more lymph nodes often affects 
the treatment plan. Still, not all women with cancer cells in their lymph nodes develop 
metastases, and some women can have no cancer cells in their lymph nodes and later 
develop metastases19,20  
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TYPES OF BREAST CANCERS 
 Breast cancer can be separated into different types based on the way the cancer 
cells look under the microscope. Most breast cancers are carcinomas, a type of cancer 
that starts in the cells (epithelial cells) that line organs and tissues like the breast. In fact, 
breast cancers are often a type of carcinoma called adenocarcinoma, which is carcinoma 
that starts in glandular tissue. Other types of cancers can occur in the breast, too, such as 
sarcomas, which start in the cells of muscle, fat, or connective tissue. In some cases a 
single breast tumor can be a combination of different types or be a mixture of invasive 
and in situ cancer. And in some rarer types of breast cancer, the cancer cells may not 
form a tumor at all. Breast cancer can also be classified based on proteins on or in the 
cancer cells, into groups like hormone receptor-positive or triple-negative21 
Ductal carcinoma in situ  
(DCIS;  known as intra ductal carcinoma) is considered non invasive or pre-
invasive breast cancer  DCIS  cells that lined the ducts have changed to look like cancer 
cells. The difference between Intra ductal carcinoma and invasive cancer is that the cells 
have not spread  through the walls of the ducts into the surrounding breast tissue. 
Because it hasn’t invaded and  can’t spread  outside the breast. Intra ductal carcinoma  is 
considered a pre-cancer because some cases can go on to become invasive cancers.  
 Invasive ductal carcinoma  
It starts in a milk ducts of the breast  and grows into the fatty tissue of the breast. 
In this stage, it may be able to spread  to other parts of the body through the lymphatic 
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system and bloodstream. About 2 in 10  invasive breast cancers are infiltrating ductal 
carcinomas.  
Invasive lobular carcinoma  
Invasive lobular carcinoma (ILC) starts in the milk-producing glands (lobules) 
and it can spread (metastasize) to other parts of the body. About 1 in 10 invasive breast 
cancers is an Invasive lobular carcinoma and may be harder to detect by a mammogram 
than invasive ductal carcinoma.  
Less common types of breast cancer  
1. Inflammatory breast cancer  
The uncommon type of invasive breast cancer accounts for about 2% to 3% of 
all breast cancers.  There is no single lump or tumor and they are inflammatory 
breast cancer  makes the skin on the breast look red and feel warmth. It also give 
the breast skin a thick, pitted appearance that looks a lot like an orange peel. The 
affected breast may become larger or firmer, tender, or itchy. 
 
                                     Figure 1: Normal Breast Tissue 
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                                               Figure 2: Ductal carcinoma in situ 
 
 
Figure 3: Inflammatory breast disease 
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2. Paget disease of the nipple  
This type of breast cancer starts in the breast ducts and spreads to the skin of the 
nipple and then to the areola, the dark circle around the nipple. It is rare, accounting for 
only about 1% of all cases of breast cancer. The skin of the nipple and areola often 
appears crusted, scaly, and red, with areas of bleeding or oozing.  
 
Figure 4: Paget disease of the nipple 
Paget disease is almost always associated with either ductal carcinoma in situ (DCIS) or 
infiltrating ductal carcinoma. Mastectomy is the treatment . If no lump can be felt in the 
breast tissue, and the biopsy shows DCIS but no invasive cancer, the outlook 
(prognosis) is excellent. If invasive cancer is present, the prognosis is not as good, and 
the cancer will need to be staged and treated like any other invasive cancer. 
3. Phyllodes tumor  
The  rare breast tumor develops in the stroma (connective tissue) of the breast, in 
contrast to carcinomas, which develop in the ducts or lobules and other names of these 
tumors are  phylloides tumor and cystosarcoma phyllodes. This type  tumors are usually 
benign and  on rare occasions may be malignant.   The Benign Phyllodes tumors are 
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treated by removing the tumor along with a margin of normal breast tissue. The  
malignant phyllodes tumor is treated by mastectomy.  
Angiosarcoma  
This type  of cancer starts in cells that line blood vessels or lymph vessels. It 
occurs in the breasts. This is an extremely rare complication of breast radiation therapy 
that can develop about 5 to 9 years after radiation. Angiosarcoma can  occur in the arms 
of women who develop lymphedema as a result of lymph node surgery or radiation 
therapy to treat breast cancer. 
DRUGS AND CHEMICALS  CAUSES BREAST CANCER 
7,12-Dimethylbenz[a]anthracene (DMBA) 22 
        DMBA is an immunosuppressant agent  and a powerful organ-specific 
laboratory carcinogen. DMBA is widely used in many research laboratories  for 
studying cancer. It  is highly lipophilic and requires metabolic activation for its 
carcinogenicity. Several tissues are capable of activating DMBA, and these include the 
mammary gland. In the breast, DMBA is converted to epoxides, active metabolites with 
a capacity for damaging the DNA molecule, the main event in carcinogenesis initiation. 
With the higher cellular proliferative index of types 1 and 2 lobules, there is higher 
metabolic activity and more epoxide formation  
 1,3-butadiene 
1,3-butadiene is an air pollutant created by internal combustion engines and 
petroleum refineries. It is also used in the manufacture and processing of synthetic 
rubber products and some fungicides and also found in tobacco smoke.  1,3-butadiene is 
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carcinogenic to humans, with the main route of exposure being through inhalation. The 
National Toxicology Program classifies 1,3-butadiene as a known human carcinogen 
.Data from research on animals indicate that females may be more vulnerable to the 
carcinogenic effects of 1,3-butadiene which is known to cause mammary and ovary 
tumors in female mice and rats.  
Pesticides 
Chlordane, Malathion and 2,4-D 
A case-control study of 128 Latina agricultural workers  diagnosed with breast 
cancer in California  with three pesticides namely chlordane, malathion and 2,4-D—
associated with an increased risk of the disease. Scientists found that use of these 
chemicals were higher in young women and in those with early-onset breast cancer than 
in unexposed women. In the animal especially in rat  mammary tissue development, 
malathion treatment led to increased proliferation of mammary cells   
Alkyl Phenols 
Alkylphenols are industrial chemicals used in the production of 
detergents,cleaning products, and as antioxidants in products made from plastics and 
rubber. They  found in  hair products. As such, people are exposed to these compounds 
in a variety of ways, including through the skin and from contamination of both air and 
water.  . The alkylphenols, including 4-NP, shown to mimic the actions of the natural 
estrogenestradiol, with their biological effects being regulated by interactions with the 
cellular estrogen receptor and bound to the cell membrane estrogen receptor and mimic 
cellular signaling responses usually controlled by estradiol .  
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Ionizing Radiation 
Ionizing radiation is any form of radiation  can break the chemical bonds in 
molecules, including DNA molecules, thereby disturbing their normal functioning. X-
rays, gamma rays are the only common forms of radiation with sufficient energy to 
penetrate and damage body tissue.. In 2005, the National Toxicology Program classified 
X-radiation and gamma radiation as human carcinogens. Repeated low-dose exposures 
over time may have the same harmful effects as a single high-dose exposure. 
. Ionizing radiation increase the risk for breast cancer through a number of 
different mechanisms, including direct mutagenesis, genomic instability, therefore 
increasing the likelihood of future mutations, and changes in breast cell 
microenvironments that can lead to damaged regulation of cell-to-cell 
communication within the breast.  
Phytoestrogens (Plant Estrogens)23,24 
Foods such as whole grains, dried beans, peas, fruits, broccoli, cauliflower and 
especially soy products are rich in phytoestrogens. Several epidemiological studies have 
shown that regular consumption of soy-based products, or other vegetables high in 
phytoestrogens, as part of a normal balanced diet can exert a protective influence against 
later development of breast cancer.. Other studies have found protective effects of soy 
intake for both pre- and post-menopausal cancer, independent of the tumors’ receptor 
profile (estrogen-receptor and progesterone-receptor positive or negative). A prospective 
study of women aged 44 to 55 years who had never been diagnosed with breast cancer 
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but were considered to be at high risk, six months of dietary isoflavone  intake was 
associated with increased proliferation of breast cells.  
KEY STATISTICS OF BREAST CANCER 25 
Breast cancer cases in urban Indian women is 30-35 and the age adjusted rate is 
35-40 new cases per lakh  women per year. Breast cancer is increasing - the average 
increase over a 35 year period in Mumbai was 12 per cent per decade. Breast cancer is 
increasing both in young (11 % per decade) and old women (16 %  per decade) There 
are an estimated 1 lakh  - 1.25 lakh  new breast cancer cases in India every year. 
The number of breast cancer cases in India is estimated to double by 2025. In 2014, 
an estimated 232,670 new cases of invasive breast cancer will be diagnosed in U.S. 
women. In addition to invasive breast cancer, an estimated 62,570 cases of carcinoma in 
situ  will be diagnosed. 
MEDICINAL PLANTS IN BREAST CANCER THERAPY  
Different  active constituents  derived from medicinal plants have been assessed 
for their efficacy and tolerability in the treatment of breast cancer. Active oxygen may 
cause cancer through two possible mechanisms:  one is gene mutations and the effects 
on signal transduction and transcription factors. Another one is oxidative stress causes 
damages to DNA, phospholipids, proteins and carbohydrates on the cell membrane. 
Oxidation and injury to DNA induce genetic mutation. Free radicals presence  may 
enhance the mutation of some genes. An antioxidant is “any substance that delays, 
prevents or removes oxidative damage to a target molecule” Antioxidants  act by diverse 
mechanisms in the oxidative sequence. Antioxidants can be classified into a number of 
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different groups as enzymatic and non enzymatic strategies. The enzymatic antioxidant 
involve superoxide dismutase, glutathione peroxidise,catalase  and glutathione 
reductase, while non enzymatic antioxidants are the vitamins A, C, and E, glutathione, 
and lipoic acid, several bioflavonoids, antioxidant minerals (copper, zinc, manganese, 
and selenium), etc 26 Antioxidants may work either alone, or in association with each 
other against different types of free radicals. Vitamin E inhibits the propagation of lipid 
peroxidation; the combination of vitamin C and vitamin E suppress the formation of 
hydroperoxide; metal complexing antioxidant such as penicillamine inhibit free redical 
formation in lipid peroxidation.  Human body is continuously generating free radicals, 
which produces  oxidative stress. Factors such as drugs, pollution, immune responses to 
viruses, deficiency of natural antioxidants, uv  rays and tobacco destroy the body 
potential of stabilizing free radicals. Endogenous sources of oxidative stress include 
mitochondria, or microsomes,. The body has the power to neutralize the free radicals , 
but if there is an imbalance between the free radicals and the ability of the body to 
neutralize it, it produces  oxidative stress. Oxidative stress may cause different problems 
and various  diseases such as diabetes, Parkinson’s disease, aging and cancer. Oxidative 
stress causes Lipid peroxidation in cell membranes reacting with polyunsaturated fatty 
acids. Cell membranes contain polyunsaturated fatty acids  and low density lipoproteins 
They are sensitive to free radicals 27,28 The molecular oxygen reacts with carbon-
centered free radicals, and thus, lipid hydroperoxides  are formed. Lipid peroxidies  alter 
the membrane structure and its functions. Free redicals cause proteins oxidation and are 
different  markers of protein oxidation, which including  protein carbonyl derivates, 
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oxidized amino acid side chains.In the oxidation process, Protein carbonyl derivates are 
formed early, and are generated as the peptide main chain as some amino acid side 
chains that are cleaved (arginine, lysine, or threonine), are also  oxidized.29,30 The 
carbonyl groups are relatively stable and may result in loss of protein function, as well 
as increased degradation of soluble proteins . Protein oxidation has also been shown to 
be a chain reaction and may be inhibited by chain-breaking antioxidants . Oxidation of 
proteins may develop some problem, but protein damage can be repaired, and is a 
nonlethal event for the cell . DNA is especially sensitive to damage due to its potential 
to create cumulative mutations, which may disrupt cellular homeostasis 31,32 DNA may 
be damaged by ROS and cause permanent structural changes in, as base-pair mutations, 
deletions, insertions, rearrangements and sequence amplification. Continuous oxidative 
damage to DNA may lead to alterations in signaling cascades or gene expression, and 
may cause replication errors and genomic instability. Cancer development is a 
multistage process which involves mutations in critical genes required for maintenance 
of the cellular homeostasis .  25% of all cancers in the world is due to chronic 
inflammation due to infection or injury. Various chemicals such as chlorinated 
compounds, metal ions, aromatic hydrocarbons and some peroxisome proliferators have 
been shown to induce oxidative stress, which damages the DNA. They may, therefore, 
partly account for the development, especially of workrelated cancers. Many cancers are 
associated with increased production of ROS. Natural products, especially plants, have 
been used for the treatment of various diseases from ancient times. People of Egypt, 
China, India and Greece have been using terrestrial plants as medicines, and a large 
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number of modern drugs have been developed from them. Medicinal plants are used in 
the treatment of different  diseases, such as liver and kidney failure , obesity,diabetes  
and cancer, etc. Many evidences showed  that the production  of free radicals inside the 
body cause damages to DNA and leads cancer, etc., and  these free redicals are 
neutralized by the antioxidants from different medicinal plants, then it prevents cancer. 
Different  studies have shown that plant derived antioxidant scavenge free radicals and 
modulate oxidative stress.33,34. The National Cancer Institute reported about 30,000 
plant samples from 25 different countries, and  screened around 115,000 extracts for 
anticancer activity. 60 percentage  of the  preparations are commercialy available 
anticancer drugs are  derived from natural plant sources. Treatment by herbal medicines 
may have some advantages over treatment by single purified chemicals as hebal 
medicine are the mixtures of more therapeutic or preventive components, and so might 
have more activity than single products seperately . The antioxidant and anti-tumor 
effects of extracts from various herbs and medicinal plants have been proved clinically. 
Different  in vitro or in vivo studies have proved the anticancer potential of the extracts 
from several medicinal plants. 35,36.  
Among Complementary and alternative medicines, herbal medicine is the most 
commonly used group of treatment of various diseases. Herbal treatment is the oldest 
method of system of medicine in the world with more than 2000 years history. Other 
names used for herbal therapy are phytomedicine, phyto-therapy and  botanical 
medicine and  made exclusively from plants such as roots, bark, flowers, seeds, fruits, 
leaves, or branches and is used in all societies and common to numerous cultures 
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including Asia, Africa,  and America..Phytoconstituents resulting from the herbs such as 
Vinca rosea, Taxus species, Allium sativum, Aloe vera, Angelica sinensis, Astragals,  
Glycyrrhiza, Hordeum vulgare, Hydrocotyle asiatica, Morinda citrifolia, Panax 
pseudoginseng, Saussurea lappa, Taxus, Tinospora cordifolia, Viscum album, Withania 
somnifera, Zingiber officinale etc. have been used in numerous preparations to improve 
function of the body’s immune cells that stimulates production of cytokines including 
interleukin, interferon, tumor necrosis factor as well as colony stimulating factor. These 
herbal preparations assist the body to fight cancer more efficiently and also decrease the 
harmful side effects of chemotherapy and radiotherapy.  Most cancer patients combine 
herbal remedies with conventional therapy in the hope of boosting the effect of 
conventional medicine .37,38 A study of women being treated for early stage breast 
cancer showed that 10.7% had been using one or more herbal remedies at the time of 
diagnosis, while an additional 28.5%began using herbal remedies after surgery 39,40 . 
Similarly a multinational survey found that 35 % of cancer patients were either past or 
present users of complementary and alternative medicine.  Herbal medicines were by far 
the most commonly used group of treatments, escalating in use from 5 % before the 
diagnosis of cancer to 13% after the diagnosis of cancer   Generally, herbal products are 
utilized for two reasons, first, to lessen symptoms of disease and second to prevent 
sickness. Examples include palliative use of St. John’s Wort (Hypericum perforatum) 
for relief of acute depression, the use of Ginkgo biloba for enhancement in 
perception/understanding and the use of Echinacea for improving cold symptom. In the 
second circumstance, herbal supplements are taken especially in the anticipation of 
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averting disease or modifying the effects of threat for certain illnesses. Such as intake of 
green tea and other flavonoid rich botanicals to yield benefit of the natural antioxidants 
in them and the consumption of garlic due to  high organo sulfur compounds that have 
been experimentally proven to prevent cancer in animals. Initiation of phase I and phase 
II metabolic enzymes by herbal supplements is quite typical and maybe liable for some 
of this action. These phase I and II enzymes provide major protection against 
carcinogenesis, mutagenesis, and other forms of toxicity mediated by carcinogens 
through initiation of their metabolism, particularly phase 2 enzymes such as glutathione 
S-transferases (GSTs), UDP-glucuronosyl transferases, and quinone reductases . Taking 
example of garlic, its intake and supplement use is prevalent in both, Eastern and 
Western cultures . Garlic along with numerous other organosulfur compounds derived 
from garlic demonstrate robust chemo-preventive action against experimentally induced 
cancers of the mammary gland as well as esophagus, stomach, colon, liver and lungs.  
Initiation of phase I and phase II enzymes, nonetheless,  result in a significant side effect 
of herbal products. 41 
Free radicals are the cause of oxidative stress, which may causes injury to cells, 
gene mutation, and may lead to cancer. Oxidative stress causes cancer, by the interaction 
with intracellular signal transduction and transcription factors, directly or indirectly. 
Medicinal plants are main sources in healing of the cancer around the world. The 
property of the plants is because of the presence of potent anti cancer substances present 
in that. Several medicinal plants have been known to cure and control cancer. Most of 
the medications used world wise contains herbal product, with  less and no side effects. 
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 Medicinal Plants in Clinical Use  
The anticancer agents such as vinblastine and vincristine from the Apocynaceae 
family , introduced a new era of the use of plant material as a medication for  cancer 
treatment. They were the first agents to advance into clinical use for the treatment of 
cancer. Vinblastine and vincristine are used in combination with other cancer drugs, for 
the treatment of different types  of cancers, including lymphomas, advanced testicular 
cancer, breast and lung cancers.49-50 The isolation of paclitaxel  from the bark of the 
Pacific Yew, Taxus brevifolia Nutt. (Taxaceae), is in the discovery of natural product 
drug. Various parts of Taxus brevifolia and other Taxus species (e.g., Taxus Canadensis 
Marshall, Taxus baccata L.) have used by several native American tribes for the 
treatment of different  types of  diseases, while Taxus baccata in India as a medicine for 
the treatment of cancer.51,52 Paclitaxel is active against a number of cancer types, for 
example: ovariancancer, advanced breast cancer and non-small cell lungcancer. 
Camptothecin was isolated from the Chinese ornamental tree, Camptotheca acuminate 
Decne (Nyssaceae), the clinical trials in the 1970s and dropped it because of severe 
bladder toxicity. Camptothecin derivatives, Topotecan and irinotecan, are used for the 
treatment of ovarian and small cell lung cancers, and colon cancers.53 
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2.AIM AND OBECTIVES OF THE STUDY 
  Treatment for Breast cancer is problematic.  Because Allopathic  drugs are 
effective against this type of breast  cancer but exhibit severe toxicity which leads to 
death .  Physicians and patients are in need of maximum therapeutic value with no or  
less side effects to improve the quality of the  life . Several herbal plants potentially 
constitute such a group. In recent years, researchers have examined the activity of plants 
used traditionally by indigenous healers and herbalists to support to treat cancer. Several 
hundred plants have been reported for use in different types of cancer treatment . Only a 
handful have been fairly well researched. After the extensive search of medicinal plant 
for  the  treatment of cancer, the plant selected for the study is Triumfetta rhomboidea 
Jacq, which belongs to the family Tiliaceae.42 The genus Triumfetta consists of about 
150 species out of which 8 are found in India. It is known as Burweed in English.It is a 
herb or under shrub with stellate pubescence. Roots of Triumfetta rhomboidea have 
been traditionally used in intestinal ulcer,dysentry and as diuretic. Leaves and stem are 
used in treatment of tumors,leprosy and Gonorrhoea. However, no reports are available 
to show the antioxidant property of the plant and the effectiveness in breast cancer.. 
  Based on the literature review there is no evidenced work done  in  the Chemo 
preventive activity of  Triumfetta rhomboidea   in 7, 12-Dimethylbenz (A) Anthracene 
induced Breast cancer in Sprague –Dawley Rat model.  The present study is planned to 
evaluate the Chemo preventive effect of methanol extract of leaves of  Triumfetta 
rhomboidea   in 7, 12-Dimethylbenz (A) Anthracene induced Breast cancer in Sprague –
dawley rat model. 
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3.REVIEW OF LITERATURE 
1. Devamurari et al 54 investigated the ethanolic extract of Triumfetta rhomboidea 
Jacq was subjected to various phytochemical tests. Preparative Thin layer 
Chromatography study of the extract was performed and active constituents were 
isolated. Spectral analysis of the isolated constituent indicates that Triumfetta 
rhomboidea (Tiliaceae) contains carbohydrate glycosides, phytosterol, steroids, 
flavonoids, tannin & phenolic compounds and triterpenoids. Antibacterial 
activity of ether and alcoholic extract of the plant was performed. Results 
exhibited that Triumfetta rhomboidea Jacq contain good antibacterial action. 
2. CD Odimegwu et al 55  investigated  the antimicrobial activity of methanol 
extract of Triumfetta rhomboidea leaves was evaluated against Staphylococcus 
aureus, Salmonella typhi and Klebsiella pneumoniae. Agar diffusion and agar 
dilution techniques were employed for the antimicrobial sensitivity and 
interaction studies. Phytochemical analysis of the crude extract was also carried 
out using standard procedures. The results obtained showed that the crude extract 
exhibits a substantial antimicrobial activity against Klebsiella 
pneumoniae (which recorded the greatest sensitivity), Salmonella typhi  but not 
against Staphylococcus aureus. Thus, this study shows that Triumfetta 
rhomboidea possesses promising antimicrobial activity especially 
against Klebsiella pneumoniae. 
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3. Uche et al 56  studied  the analgesic and anti-inflammatory effects of the 
methanolic extract of the leaves of Triumfetta rhomboidea on mice and rats 
respectively. And to screen the phytochemical constituent of the extract. The 
analgesic effect was determined by acetic acid-induced writhing test in mice. 
While the anti-inflammatory activity was determined by egg albumin-induced 
oedema of the rat paw. Triumfetta rhomboidea extract caused a statistically 
significant reduction in the number of acetic acid-induced writhing in mice, 
withP<0.001 (ANOVA). 
4. Prasad et al57determined experimentally the possible Antibacterial Activity of 
Water Extract and Active constituents were Isolated of Butanol from a 
Triumfetta rhomboidea and Analytical Study by HPLC Method. The 
Antibacterial activity of the Water Extract of Triumfetta rhomboidea was 
evaluated at two different concentrations by the diffusion method. The Bacteria 
B. cereus was found to be more active and E. coli, S. aureus was found to be less 
active in inhibition zone. .Antibacterial activity of water extract of the plant was 
performed. Results exhibited that Triumfetta rhomboidea contain good 
Antibacterial action and Active constituents were Isolated of Butanol. 
5. Rozina Parul et al58 studied  the methanolic extracts of three medicinal plants 
named Phyllunthus freternus, Triumfetta rhomboidae and Casuarina littorea 
were examined for their possible regulatory effect on nitric oxide (NO) levels 
using sodium nitroprusside as a NO donor in vitro. Most of the extracts tested 
demonstrated direct scavenging of NO and exihibited significant activity and the 
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potency of scavenging activity was in the following order: Phyllunthus freternus 
> Leaves of Triumfetta rhomboidae > Casuarina littorea > barks of Triumfetta 
rhomboidae > roots of Triumfetta rhomboidae. All the evaluated extracts 
exhibited a dose dependent NO scavenging activity. 
6. P Sivakumar et al 59 proved  experimentally the possible antitumor effect and 
antioxidant role of methanol extract of Triumfetta rhomboidea (METR) leaves 
against Ehrlich ascites carcinoma (EAC) bearing Swiss albino mice. The METR 
administered at the doses of 100, 200 mg/kg, in mice for 14 days after 24 hours 
of tumor inoculation. The effects of METR on the growth of murine tumor, life 
span of EAC bearing mice were studied. Hematological profile and liver 
biochemical parameters (lipid peroxidation, antioxidant enzymes) were also 
estimated. 
7. P. Lissy et al 60   studied methanolic extract of Sida retusa Linn. 
(Malvaceae),Urena lobata Linn.(Malvaceae)and Triumfetta rhomboidea 
Jacq.(Teliaceae) roots were found to inhibit lipid peroxidation, scavenge 
hydroxyl and superoxide radicals in vitro.. IC 50 of root extract of U.lobata was 
470. 60 ug/ml, 1627.35ug/ml and 1109.24 ug/ml for superoxide radical 
scavenging, hydroxyl radical scavenging and lipid peroxidation respectively. 
T.rhomboidea root extract required for IC 50 was 336.65 ug/ml, 1346.03 ug/ml 
and 1004.22 ug/ml for superoxide scavenging, hydroxyl radical scavenging and 
lipid peroxidation respectively. 
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8. N Suganthi et al61 investigated  the antidiabetic effect of ethanolic extract of 
Triumfetta rhomboidea was investigated in alloxan induced diabetes rats. Oral 
administration of ethanolic extract of Triumfetta rhomboidea at the doses of 100, 
200, and 400 mg / kg body weight was studied in alloxan induced diabetic rats. 
The activity of the plant extracts was comparable with glibenclamide, a well 
known antidiabetic drug. The result clearly suggests that ethanolic extract of 
Triumfetta rhomboidea posses’ significant antidiabetic activity. 
9. J P Mevy et al 62 proved  the essential oil of the aerial parts of Triumfetta 
rhomboidea  was analysed by GC and GC-MS and assayed for its antibacterial 
and antifungal activities. The main constituents identified were trans-β-
caryophyllene (22.4%), kessane (14%) and caryophyllene oxide (13%). The 
antimicrobial tests showed a mild activity against Escherichia 
coli and Enterococcus hirae.  
10. Natla Sashidhar Reddy et al 63 studied  that  Quercetin supplementation at the 
dose of 100 mg kg-1 body weight was most effective in alleviating cancer 
symptoms and was comparable to vincristine. The plasma TBARS were reduced 
and breast tissue TBARS were elevated. The antioxidant enzymes were 
rejuvenated by quercetin supplementation at all three dose levels. Quercetin is 
found to be an effective chemotherapeutic agent in the treatment of breast cancer 
on par with vincristine. Being a plant product, quercetin can also be used in 
chemoprophylaxis in high risk individuals with genetic predisposition towards 
breast cancer. Besides, it can be given orally and has a wide margin of safety. 
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11. T.Rengarajan et al 64 reported 7, 12-dimethylbenz (a)anthracene(DMBA) acts 
as a potent site and organ specific carcinogen by generating various reactive 
metabolic intermediates leading to oxidative stress. Female Sprague Dawley rats 
were divided into four groups and each group consisting of six animals. Group I 
and group IV were vector and drug control. The group II and group III animals 
were treated with DMBA 20 mg/kg bodyweight to induce mammary carcinoma. 
Rats received cancer bearing Group III animals were treated with D-Pinitol at the 
concentration of 30 mg/kg bodyweight for 45 days orally. At the end of the 
experimental period all the rats were sacrificed. The breast and liver tissues 
levels of the enzymic and non-enzymic antioxidants were significantly decreased 
in cancer bearing animals when compared to the control animals. Phase I and II 
xenobiotic metabolizing enzymes and Lipid peroxide levels (LPO) were 
estimated. Western blotting analysis showed over expression of Bcl-2 in the 
mammary tissue of DMBA induced group II rats. From our results, we conclude 
that D-Pinitol is a potent antioxidant and play a protective role against DMBA 
induced breast cancer. 
12.  Margarida F et al 65 studied that Combined chemopreventive effects of alpha 
tocopherol and selenium in rodent tumours seem to be more promising than that 
of selenium or alpha tocopherol alone.On the  otherhand the effect of  ascorbic 
acid alone in some tumour model system is not consistent or appears to be weak. 
The combined effects vitamin C and selenium depends on the chemical form of 
the selenium compound. This experimental study was designed to evaluate 
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mixture of three micro nutrients. Results point to an effective chemopreventive 
action of this mixture in reducing the incidence and preventing the development 
of malignant tumours in this animal model. 
13. Haiming Ding et al66  reported  Avocado extract Inhibited (DMBA)- Induced 
Carcinogenesis in Hamster Cheek Pouches and  shown that an avocado extract  
selectively inhibits proliferation in premalignant and malignant and not normal 
primary human oral epithelial cell lines via an ROS-mediated mechanism. 
Herein, the in vivo anticancer effect of D003 extract and freeze-dried avocado 
(FA) was determined in the DMBAinitiated hamster cheek pouch (HCP) model. 
14.  Veena Sharma et al 67   studied Present investigation shows that hydroethanolic 
extract of Moringa oleifera (MOHE) and its isolated saponin (SM) attenuates 
DMBA induced renal carcino-genesis in mice. Isolation of SM was achieved by 
TLC and HPLC and characterization was done using IR and 1 H NMR. Animals 
were pre-treated with MOHE (200 and 400 mg/kg body weight; p.o), BHA as a 
standard (0.5 and 1 %) and SM (50 mg/kg body weight) for 21 days prior to the 
administration of single dose of DMBA (15 mg/kg body weight). Administration 
of DMBA significantly (p \ 0.001) enhanced level of xenobiotic enzymes. It 
enhanced renal malondialdehyde, with reduction in renal glutathione content, 
antioxidant enzymes and glutathione-S-transferase. The status of renal aspartate 
transaminase, alanine transaminase, alkaline phosphatase and total pro-tein 
content were also found to be decreased along with increase in total cholesterol 
in DMBA administered mice. Pretreatment with MOHE and SM significantly 
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reversed the DMBA induced alterations in the tissue and effectively suppressed 
renal oxidative stress and toxicity 
15. Jyoti Parma et al 68  reported that Investigation of cancer chemopreventive and 
anti-oxidative property of S.cumini seed extract (SCE) on 7,12-dimethyl 
benz(a)anthracene (DMBA) induced skin carcinogenesis in mice. Animals were 
divided into four groups on the basis of their respective treatments wherein mice 
of Group I & II served as vehicle treated and SCE treated controls respectively. 
For induction of skin tumors, mice of Group III and IV were applied topically 
with 7,12-dimethylbenz(a)anthracene (DMBA) followed 2 weeks later by 
repeated application of croton oil (1% in acetone three times a week) and 
continued till the end of the experiment (i.e. 16 weeks). Mice of Group IV were 
administered S.cumini seed extract (SCE) at peri- & post-initiational stage. The 
results of the study revealed a significant decrease in incidence, cumulative 
number of papillomas, tumor yield and tumor burden in mice of Group IV as 
compared with DMBA alone at the end of experiment. A significant reduction in 
tumor weight and tumor volume was also observed. Reduction in the incidence 
and number of papilloma, the preneoplastic lesions, was considered to be the 
mean of assessment. 
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4.MATERIALS AND METHODS 
4.1 PLANT PROFILE 
4.1.1.Botanical  Information 
 
                                        TRIUMFETTA RHOMBOIDEA N. Jacq 
 
 
 
  
 
 
 
 
 
 
 
Classification Triumfetta Rhomboidea 
Kingdom  Plantae 
Division Tracheophyta 
Class Magnoliopsida 
Order  Malvales 
Family  Malvaceae 
Genus  Triumfetta 
Species  Triumfetta Rhomboidea 
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Vernacular Names             
Hindi     : Burr Bush, Chinese Burr,  
Tamil     : Ottu Pulli  
Telugu    : Bankathuthara 
Bengali    : Bon okhra    
Kannada  : Kadu bende  
Assamese :  Agra 
4.1.2. Description of the Plant 43-45 
An annual undershrub, 0.6-1.5 m high; branches slender, more or less pubescent. 
Leaves variable, lower leaves 5-7.5 cm diam, usually 3-lobed, irregularly serrate, 
clothed with stellate hairs on both surfaces; upper leaves usually simple, with very short 
petioles. Flowers 6 mm across, yellow in dense terminal and leaf-opposed cymes. 
Capsule subglobose, 4 mm diam., echinate with hooked bristles. 
ChemicalConstituents:46 
           A flavone glycoside, triumboidin, Friedelin, Friedelinol  has been isolated from 
this plant. It also contains small amounts of other flavones and flavonoids. Seeds contain 
a fixed oil and proteins 
Ethnomedicinal  uses:47,48 
          Fruits, flowers and leaves are used as astringent and  demulcent . Bark and fresh 
leaves are traditionally used in diarrhoea ,dysentery,Inflammation, Diabetes Mellitus, 
Peptic ulcer  and cancer of Breast.  Flowers rubbed with sugar and water is given in 
gonorrhoea to stop burning sensation . Fruits are used to promote parturition. Roots are 
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used as tonic, diuretic and cooling; used in dysentery; hot infusion is taken by the 
women to facilitate childbirth. 
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4.2 PHYTOCHEMICAL EVALUATION 
4.2.1.Collection and Authentication of plant  
The fresh healthy plant leaves of Triumfetta rhomboidea   was  collected from  
Irular society, Thandarai, TamilNadu, India during the month of December 2013. The 
plant was identified and authenticated by Botanical Survey of India, Coimbatore and a 
voucher specimen has been preserved in the Department of Pharmacognosy, R.V.S. 
College of Pharmaceutical sciences, sulur, Coimbatore. After authentification, the fresh, 
healthy plant leaves of Triumfetta rhomboidea   was properly dried in shade for 2-
3weeks. It was pulverized in a blender, sieved and used for further studies.  
4.2.2.Preparation of the Extracts  
About 2 kg of shade dried plant leaves of Triumfetta rhomboidea   extracted in 
soxhlet successively extracted with n-hexane, chloroform, ethyl acetate and methanol. 
Each extract was evaporated by using rotary vacuum evaporator. The extract obtained 
with each solvent was weighed and the percentage yield was calculated in terms of dried 
weight of the plant leaves. The Consistency and Colour of the extract were noted. All 
the solvents used for this work were of analytical grade. 
4.2.3.Qualitative chemical tests 69 
  The n-hexane, chloroform, ethyl acetate, methanol extracts of the leaf powder of 
Triumfetta rhomboidea   was subjected to qualitative chemical analysis. 
1. Test for alkaloids  
The extract was stirred separately with a few drops of dilute hydrochloric acid and 
filtered. The filtrate was tested with different alkaloidal reagents  
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a) Mayer’s reagent  
Treated with Mayer’s reagent  (mixture of potassium and mercuric chloride). 
Appearance of cream colour precipitate indicates the presence of alkaloids  
b) Dragondroff’s reagent  
Extract is treated with Dragondroff’s reagent (Sodium nitoprusside and iodine). 
Appearance of orange colour precipitate indicates  the presence of alkaloids. 
c) Hager’s reagent 
Extract is treated with Hager’s reagent (saturated aqueous solution of picric 
acid). Appearance of yellow precipitate indicates the presence of alkaloids.  
d) Wagner’s reagent 
 Extract is treated with Wagner’s reagent (Iodine in Potassium iodide). 
Appearance of reddish brown precipitate indicates  the presence of alkaloids. 
2. Test for carbohydrates  
The minimum amount of the extracts were dissolved in 5ml of distilled water 
and filtered. The filtrate was used to test for carbohydrates. 
a) Molisch’s test 
 It was treated with 2-3 drops of 1% alcoholic alpha napthol and 2ml of 
concentrated sulphuric acid was added along the sides of the test tube. Formation of 
violet colour ring at the junction of two layers confirms the presence of 
carbohydrates. 
 
 
CHEMOPREVENTIVE ACTIVITY OF SOME MEDICINAL PLANT ON 7,12- DMBA 
INDUCED BREAST CANCER 
 
   Mr R.SURESH                               PH.D THESIS – JUNE 2017                                 Page 39 
 
b) Fehling’s test  
The filtrate was treated with 1 ml of Fehling’s A and B and heated in a boiling 
water bath for 5-10min. Appearance of reddish orange precipitate confirms the 
presence of carbohydrates .  
3. Test for glycosides  
a) Cardiac glycoside Keller-Killani test- To 2 ml of extract, glacial acetic acid, 
one drop 5 % ferric chloride and concentrated sulphuric acid were added. 
Formation of reddish brown colour at the junction of the two liquid layers 
indicates the presence of cardiac glycosides. 
b) Saponin glycosides Foam test – The extract and powder was mixed 
vigorously with water. Appearance of foam shows the presence  of Saponins  
c) Anthraquinone glycosides Borntrager’s Test – To extract dilute sulphuric 
acid was added, boiled and filtered. The cold filtrate equal volume benzene or 
chloroform was added. The organic layer was separated and ammonia was 
added. Ammonical layer changed to pink or red.  
d) Coumarin glycosides -Methanol extract when made alkaline, shows blue or 
green fluorescence. 
  4. Test for phytosterol 
 1gm of the methanol extract was dissolved in few drops of dry acetic acid; 
acetic anhydride (3ml) was added and few drops of concentrated sulphuric acid. Bluish 
green colour confirms the presence of phytosterol. 
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 5. Test for fixed oils and fats 
(a) Filter paper Test:- Various extracts was separately pressed between two 
filter papers. Appearance of oil stains on the paper indicates the presence of 
fixed oil.  
(b) Saponification Test:- Few drops of 0.5N alcoholic KOH is added to a small 
quantity of extracts along with a drop of phenolphthalein. The mixture was 
heated for 1-2 hours. Formation of soap or partial neutralization of alkali 
indicates the presence of fixed oil and fats.  
6. Test for tannins and phenolic compounds  
Small quantity of various extracts were taken separately in water tested for the 
presence of phenolic compounds and tannins with  
(a) Dilute ferric chloride solution (5%) formation of violet colour indicates the 
presence of phenolic compounds.  
(b) 1% solution of gelatin with 10%NaCl formation of white precipitate 
indicates the presence of tannins. 
(c) 10% lead acetate solution formation of white precipitate indicates the 
presence of tannins.  
7. Test for proteins  
Various extracts were dissolved in few ml of water and treated with  
(a) Millon’s reagent gives the appearance of red colour shows the presence of 
proteins and free amino acids.  
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(b) Biuret test: Equal volume of 5% solution of sodium hydroxide and 1% 
copper sulphate were added. Appearance of pink or purple colour indicates the 
presence of proteins and free amino acids.  
8. Test for gums and mucilage  
About 10ml of various extracts were added separately to 25ml of absolute 
alcohol with constant stirring and filtered. The precipitate was dried in air and 
examined for its swelling properties and for the presence of carbohydrates. 
9. Test for flavonoids 
(a) With aqueous solution of sodium hydroxide blue to violet colour 
(Anthrocyanins), yellow colour (Flavones), yellow to orange (Flavonones).  
(b) With concentrated sulphuric acid yellowish orange colour (Anthrocyanins), 
orange to crimson colour (Flavonones).  
(c) Shinoda’s test – the extracts were dissolved in alcohol, to that a piece of 
magnesium and followed by concentrated hydrochloric acid was added drop 
wise and heated. Appearance of magenta colour shows the presence of 
flavonoids.  
10. Test for terpenoids Noller’s test 
The substance was warmed with thionyl chloride and Tin. Pink color indicates 
the presence of triterpenoids. 
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11. Test for steroids Libermann – Burchard Reaction  
2ml extract was mixed with chloroform. To this 1-2 ml acetic anhydride and 2 drops 
concentrated sulphuric acid were added from the side of test tube. First red, then blue 
and finally green colour appears. 
4.2.4. Thin Layer Chromatography of methanol extracts of Triumfetta 
rhomboidea70,71 
Of the various methods of separating and isolating plant constituents, thin layer 
chromatography (TLC) is one of the most powerful techniques used for the separation, 
identification and estimation of single or mixture of components present in various 
extracts. Mechanism employed in this reliable technique is adsorption in which solute 
adsorbs on the stationary phase according to its affinity. Substances are separated by 
differential migration that occurs when a solvent flows along the thin layer of stationary 
phase. The substance which is having more affinity towards mobile phase moves faster 
when compared to the substance which has less affinity leading to the separation of the 
compounds. 
TLC Plates 
Precoated silica gel on aluminium plates were used as a stationary phase. 
Sample application 
The extracts to be analyzed were diluted with respective solvents and then 
spotted with help of capillary tube just 2 cm above its bottom. 
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Selection of mobile phase 
Solvent mixture was selected on the basis of the phytoconstituents present in 
each extract. Solvents were analyzed as its order of increasing polarity. Several mobile 
phases were tried for the separation of maximum components. After several trials, the 
best solvent system was selected which showed good separation with maximum number 
of components. 
Solvent system 
Methanol: Ethyl acetate: Water (6:3:1) 
Rf values were noted down for each selected extracts after elution by using 
different detecting agents such as Dragondroff’s, Ninhydrin, Libermann Burchard, 
concentrated sulphuric acid and ferric chloride. 
4.2.5. High Performance Thin Layer Chromatography of methanol extract of 
Triumfetta rhomboidea 
HPTLC method is a modern sophisticated and automated separation technique 
derived from TLC. Pre-coated HPTLC graded plates and auto sampler was used to 
achieve precision, sensitive, significant separation both qualitatively and quantitatively. 
High performance thin layer chromatography (HPTLC) is a valuable quality assessment 
tool for the evaluation of botanical materials efficiently and cost effectively. HPTLC 
method offers high degree of selectivity, sensitivity and rapidity combined with single-
step sample preparation. In addition it is a reliable method for the quantization of 
nanograms level of samples. Thus this method can be conveniently adopted for routine 
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quality control analysis. It provides chromatographic fingerprint of phytochemicals 
which is suitable for confirming the identity and purity of medicinal plant raw materials. 
Basic steps involved in HPTLC 
Extracts used             :  Methanol 
Application mode      :  CAMAG Linomet IV. 
Development mode   :  CAMAG Twin Trough chamber. 
Sample application 
The samples were dissolved in same solvent and 10μl quantity of sample was 
applied on the HPTLC silica merk 60F 254 graded plate sized 6cm x 10 cm as narrow 
bands using CAMAG Linomat 5 injector. 
Chromatogram Development  
It was carried out in CAMAG Twin Trough chambers. Sample elution was 
carried out according to the adsorption capability of the component to be analyzed. After 
elution, plates were taken out of the chamber and dried. 
Scanning 
Plates were scanned under UV at 254nm. The data’s obtained from scanning 
were brought into integration through CAMAG software. Chromatographic finger print 
was developed for the detection of phytoconstituents present in each extract and Rf 
values were tabulated. 
Mobile Phase 
n-Butanol(4): Water(5): Acetic acid(1). 
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 4.3. INVITRO FREE RADICAL SCAVENGING ACTIVITY 
 
4.3.1.DPPH Radical Scavenging Activity 72-75 
Free radical scavenging effect was determined  according to the method of Blois  
as modified  by zang et al . Briefly, a 1mM solution of DPPH radical solution in 
methanol was prepared, and then 1mL of this solution was mixed with different 
concentrations of methanol extract; the mixture was then vortexed vigorously and left 
for 30 min at room temperature in the dark and the absorbance was measured at 517 nm 
with a spectrophotometer and was  calculated. DPPH Scavenging activity % = [(Control 
Absorbance – Extract Absorbance)/Control Absorbance] x 100. For control 1.0 mL of 
methanol was added to 1mL of 1mM solution of DPPH radical solution and the rest of 
the procedures remain the same. 
4.3.2.Superoxide Radical Scavenging Assay 76-79 
The superoxide radical scavenging activity of the extracts was determined  
according to the literature method and containing PMS (0.1 mmol/L), NADH (1 
mmol/L), NBT (1 mmol/L) in phosphate buffer (0.1 mol/L, pH 7.4) with different 
concentrations of the extract was incubated at room temperature for 5 min and the color 
was read at 560 nm against a blank. The scavenging effect was calculated against the 
control  
 4.3.3.Nitric Oxide Radical Inhibition Assay 80 
Nitric oxide generated from sodium nitroprusside in aqueous solution at 
physiological pH interacts with oxygen to produce nitrite ions which were measured by 
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Griess reaction. The reaction mixture (3ml) containing sodium nitropruside (10mM) in 
phosphate buffered saline and the varying concentrations of extract and control were 
incubated in water both at 25oC for 30 minutes. After incubation, 1.5ml mixture were 
removed and 1.5 of Griess reagent was then added. The absorbance of the chromophore 
formed was evaluated using spectrophotometer at 546nm. NO Scavenging activity % = 
[(Control Absorbance – Extract Absorbance)/Control Absorbance] x 100. For control 
1.0 mL of buffer was added to 3mL of 10mM sodium nitropruside and the rest of the 
procedures remain the same. 
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4.4. ACUTE TOXICITY STUDY 
4.4.1.Plant extract  
 The therapeutically active extract  of Triumfetta rhomboidea Methanol extract 
(TRM)  to carry out the pharmacological studies in animals was selected on the basis of 
in- vitro studies like in-vitro free radical scavenging activity and phytochemical 
analysis. 
 4.4.2.Experimental animals  
Adult male Wister rats weighing 100-150g were obtained from R.V.S. College 
of Pharmaceutical Sciences, Sulur, Coimbatore. They were maintained at standard 
housing conditions and fed with commercial diet and provided with water and libitum 
during the experiment. The institutional animal ethics committee (Reg.no 
1012/C/06/CPCSEA) permitted the study. The animals were kept in clean and dry 
polycarbonate cages and maintained in a well ventilated animal house with 12hrs light – 
12 hrs dark cycle.  
4.4.3.Acute toxic class method 81,82 
Acute toxicity study was done according to OECD guidelines 423 (Organization 
of Economic Co-Operation and Development). It is a procedure with three animals of 
single sex per step. Based on the mortality and morbidity status of the animal, average 
of 2-4 steps necessary to allow decision on the test substance. The procedure is to fix a 
minimal number of animals, which allows acceptable database scientific conclusion. 
The method uses different doses (5, 50, 500, 2000mg/kg body weight) Procedure Three 
healthy, Wistar Albino rats weighing 150-200gms were selected for the study. The rats 
were fasted over-night and provided with water ad libitum. Following the period of 
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fasting, the animals were treated with the methanolic extract at the dose of 2000mg/kg 
body weight, orally. As most of the crude extracts possess LD50 value more than 
2000mg/kg body weight and this was used as starting dose. After oral administration, 
the rats were observed for 24hrs to access mortality and to observe any changes in the 
autonomic or behavioral responses viz. aggressiveness, alertness, irritability, 
spontaneous activity, corneal reflex, tremor, salvation, urination, convulsion and 
respiration etc. The rats were observed regularly for 14 days to note the mortality or 
toxic symptoms. Since there was no death as per the guidelines, the study was repeated 
with the same dose to confirm the results. 
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4.5 PHARMACOLOGICAL SCREENING 
4.5.1. SCREENING OF 7,12  DIMETHYL BENZ ANTHRACENE INDUCED 
BREAST CANCER 83-86 
Experimental design  
Forty rats were divided into four groups and each group contained ten rats.  
Group I rats received the excipient (single dose of 1 mL of emulsion of sunflower oil 
and physiological saline, s.c.) and 1 mL of 2% DMSO (p.o.) throughout the 
experimental period served as vehicle treated control.  
Groups II , III  and IV rats were induced mammary carcinogenesis by providing single 
subcutaneous injection of 25 mg of DMBA. Group 2 rats received no other treatment.  
Group III, IV and V rats were orally administered with  TRM 100 , 200 mg kg-1 b.wt.,  
and 5mg/kg  of  Tamoxifen  as a standard dissolved in 2% DMSO  starting one week 
before the exposure of the carcinogen respectively and continued till the experimental 
period.  
The experiment was terminated at 16th week to evaluate the chemopreventive 
effect of  TRM during DMBA-induced mammary carcinogenesis. All rats were 
sacrificed by cervical dislocation at the end of experimental period to evaluate the tumor 
incidence and tumor volume in control and experimental rats in each group. 
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Biochemical Estimation  
                   Blood samples were collected into heparinized tubes. Plasma was separated 
by centrifugation at 1000x g for 15 min. Tissue samples from rats were washed with ice 
cold saline and dried between folds of filter paper, weighed and homogenized using 
appropriate buffer in an All-glass homogenizer with teflon pestle and used for 
biochemical estimations Lipid peroxidation was estimated as evidenced by the 
formation of thiobarbituric acid reactive substances (TBARS). TBARS in plasma were 
assayed by the method of Yagi 87 (1987). Tissue lipid peroxidation was done by the 
method of Ohkawa et al. 88(1979). The activities of superoxide dismutase(SOD), 
catalase (CAT) and Glutathione Peroxidase (GPx) were assayed by the method 
of Kakkar et al. 89 (1984), Sinha 90 (1972) and Rotruck et al. 91(1973) respectively. The 
GSH level in plasma and mammary tissues was determined by the method of Beutler 
and Kelley (1963)92.Chemiluminescent immunoassay (CLIA) was used for the 
estimation of serum 17 β-estradiol (E2) 
Histopathology  
For histopathological studies, tumor tissues and normal mammary gland tissues 
were fixed in 10% formalin and were routinely processed and paraffin embedded, 2-3 
μm sections were cut in a rotary microtome and were stained with hematoxylin and 
eosin. 
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4.5.2. IN VIVO ANTI-TUMOR ACTIVITY 
Cell Lines 
Dalton’s lymphoma ascites tumor cells (DLA) and Ehrlich ascites carcinoma 
cells (EAC) maintained in Amala Cancer Research Centre, Thrissur, Kerala, were used 
for the assay.  
Maintaining of tumor cell lines 
Dalton’s Lymphoma Ascites (DLA) and Ehrlich’s Ascites Carcinoma (EAC) 
cells were maintained in the ascites fluid of the peritoneal cavity of mouse. The 
aspirated tumor cells were washed 3 times with PBS (pH-7.4) and adjusted the cell 
count to 1×106 cells/ml using haemocytometer.  Approximately, 1×106 cells were 
injected intraperitoneally to develop ascites tumor in mice. 
In vivo Anti-tumor activity  
 For assessing the antitumor activity, Dalton’s Lymphoma Ascites (DLA) cell 
induced solid tumor model and Ehrlich Ascites Carcinoma (EAC) cell induced ascites 
tumor model were employed. 
EAC induced ascites tumor model system 93-95 
Male Swiss Albino mice were grouped into four groups (6 animals per each 
group).  
 Group I:  Control – Untreated;  
Group II:  Standard – Cyclophosphamide 10mg/kg;  
Group III: TRM (100 mg/kg b.wt) 
Group IV: TRM (200 mg/kg b.wt) 
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 EAC cells were aspirated from peritoneal cavity of the tumor bearing mice and 
0.1ml containing 1x106cells/ml was injected intraperitoneally into all the animals. The 
drug administration has started next day after the induction of tumor and continued for 
10 consecutive days. The animals were observed for the development of ascites tumor 
and death due to tumor burden was recorded for 30 consecutive days. The life span of 
animals was calculated using the formula, 
 %ILS = (T-C)/C × 100, where T and C are mean survival of treated and control 
mice respectively. 
DLA induced solid tumor model system 96-97 
Assessment of tumor volume 
Male Swiss Albino mice were grouped into four  groups (6 animals per each 
group).  
Group I: Control – Untreated;  
Group II: Standard – Cyclophosphamide 10mg/kg;  
Group III: TRM (100 mg/kg b.wt) 
Group IV: TRM (200 mg/kg b.wt). DLA cells were aspirated from peritoneal cavity of 
the tumor bearing mice and 0.1ml containing 1x106cells/ml was injected intramuscularly 
into the right hind limb of all the animals. The drug administration was started next day 
after the induction of tumor and continued for 10 consecutive days. The tumor 
development on animal in each group was determined by measuring the diameter of the 
tumor growth in two perpendicular planes using a vernier caliper at fixed intervals (on 
each 3rd day) and the volume was calculated using the formula,  Tumor volume = 4/3 π 
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r1
2 X r2 where r1is the minor radius and r2 is the major radius.And the percentage of 
inhibition of tumor volume in animals was calculated by, % of inhibition = [(tumor 
volume of control on 30th day – Tumor volume of treated on30th) / (Tumor volume of 
control on 30th day)] × 100 
STATISTICAL ANALYSIS 
The results were expressed as mean ± SEM of six animals from each group. The 
statistical analysis were  carried out by one way analysis of variance (ANOVA)  P 
values < 0.05 were considered significant. 
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4.5.3.DOCKING ANALYSIS 
Computational Biology and bioinformatics have the potential not only of 
speeding up the drug discovery process thus reducing the costs, but also of changing 
the way drugs are designed.  Rational drug design  helps to facilitate and speedup the 
drug designing process, which involves variety of methods to identify novel 
compounds. One such method is the docking of the drug molecule with the receptor 
(target).  The site of drug action, which is ultimately responsible for the 
pharmaceutical effect, is a receptor and docking is the process by which two molecules 
fit together in 3D space. A bioactive compounds has been already reported from the 
leaves of Triumfetta rhomboidea   .The aim of the present study is to investigate the 
inhibitory activity of the compounds on breast cancer  by  molecular docking studies 
and to analyze the  ADME/T properties of the compounds  
Compound 1- Friedelin 
                                  Compound 2-  Friedelinol 
Compounds 1 and 2 were used for docking on BRCA1( Breast Cancer Gene 1). 
Glide docking uses the assumption of a rigid receptor, although scaling of vander Waals 
radii of nonpolar atoms, which decreases penalties for close contacts, can be used to 
model a slight “give” in the receptor and/or ligand. Docking studies of designed 
compounds were carried out using GLIDE (Grid-based Ligand Docking with 
Energetics) module version 5.9. Schrödinger, LLC, New York, NY, 2013. The software 
package running on multi-processor Linux PC. GLIDE has previously been validated & 
applied successfully to predict the binding orientation of many ligands. 
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Software’s handled 98-101 
• GLIDE  module version 5.9.,  mastero 9.4 
• Quik prop -3.6 -Schrödinger, LLC, New York, NY, 2013- docking 
• Swiss PDB viewer-4.04 – protein viewer  
• Pymol viewer 1.3 – image viewer 
• Marveen sketch 5.5 – drawing ligand structure 
Ligand structure 
 The chemical structure of each ligand was drawn using build module. 
1. Structure of  Structure of  Friedelin 
 
2.  Structure of Friedelinol 
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Ligand preparation 
  In order to prepare high quality, all-atom 3D structures for large numbers of 
drug-like molecules, starting with the 3D structures in SD Maestro format, Lig Prep 
was used. Lig Prep produced a single, low-energy, 3D structure with corrected 
chiralities for each successfully processed input structure. 
Preparation of protein  
 The typical structure file from the PDB is not suitable for immediate use in 
molecular modelling calculations. A typical PDB structure file consists only of 
heavy atoms and may include a co-crystallized ligand, water molecules, metal ions, 
and cofactors. Some structures are multimeric, and may need to be reduced to a 
single unit. Because of the limited resolution of X-ray experiments, it can be difficult 
to distinguish between NH and O, and the placement of these groups must be 
checked. PDB structures may be missing information on connectivity, which must be 
assigned, along with bond orders and formal charges. This was done using the 
Protein Preparation Wizard. 
Receptor Grid Generation 
 Receptor grid generation requires a “prepared” structure: an all atom structure 
with appropriate bond orders and formal charges. Glide searches for favourable 
interactions between one or more ligand molecules and a receptor molecule, usually 
a protein. The shape and properties of the receptor are represented on a grid by 
several different sets of fields that provide progressively more accurate scoring of 
the ligand poses. The options in each tab of the Receptor Grid Generation panel 
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allow defining the receptor structure by excluding any co-crystallized ligand that 
may be present, determine the position and size of the active site as it will be 
represented by receptor grids, and set up Glide constraints. A grid area was 
generated around the binding site of the receptor. 
Ligand Docking: 
 This is carried out using GLIDE DOCK. Glide searches for favourable 
interactions between one or more ligand molecules and a receptor molecule, usually 
a protein. Each ligand acts as single molecule, while the receptor may include more 
than one molecule, e.g., a protein and a cofactor. Glide was run in rigid or flexible 
docking modes; the latter automatically generated conformations for each input 
ligand. The combination of position and orientation of a ligand relative to the 
receptor, along with its conformation in flexible docking, is referred to as a ligand 
pose. The ligand poses that Glide generates pass through a series of hierarchical 
filters that evaluate the ligand’s interaction with the receptor. The initial filters test 
the spatial fit of the ligand to the defined active site, and examine the 
complementarily of ligand-receptor interactions using a grid-based method patterned 
after the empirical Chem-Score function. Poses that passed these initial screens 
entered the final stage of the algorithm, which involves evaluation and minimization 
of a grid approximation to the OPLS-AA non bonded ligand-receptor interaction 
energy. Final scoring is then carried out on the energy-minimized poses. 
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Glide Extra-Precision Mode (XP)  
The extra-precision (XP) mode of Glide combines a powerful sampling protocol 
with the use of a custom scoring function designed to identify ligand poses that 
would be expected to have unfavourable energies, based on well-known principles of 
physical chemistry. The presumption is that only active compounds will have 
available poses that avoid these penalties and also receive favourable scores for 
appropriate hydrophobic contact between the protein and the ligand, hydrogen-
bonding interactions, and so on. The chief purposes of the XP method are to weed 
out false positives and to provide a better correlation between good poses and good 
scores. Extra-precision mode is a refinement tool designed for use only on good 
ligand poses. Finally, the minimized poses are re-scored using Schrödinger’s 
proprietary Glide-Score scoring function. Glide-Score is based on Chem-Score, but 
includes a steric-clash term and adds buried polar terms devised by Schrodinger to 
penalize electrostatic mismatches: 
Glide Score = 0.065*vdW + 0.130*Coul + Lipo + Hbond + Metal + BuryP + 
RotB + Site 
Docking Procedure  
Docking studies of 2 compounds were performed using 1protein obtained from 
the RCSB Protein Data Bank, http://www.rcsb.org/pdb.  
Experiments were performed using the program GLIDE (Grid-based Ligand 
Docking with Energetic) module version 5.9, Schrödinger, LLC, New York, NY, 2013 
(Schrodinger Inc.). Coordinates of the full-length substrate-complexed dimmer were 
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prepared for Glide 5.9 calculations by running the protein preparation wizard. The p-
prep script produces a new receptor file in which all residues are neutralized except 
those that are relatively close to the ligand (if the protein is complexed with a ligand) 
or form salt bridges. The impref script runs a series of restrained impact energy 
minimizations using the Impact utility. Minimizations were run until the average root 
mean square deviation (rmsd) of the non-hydrogen atoms reached 0.3Å. Glide uses 
two boxes that share a common centre to organize its calculations: a larger enclosing 
box and a smaller binding box. The grids themselves are calculated within the space 
defined by the enclosing box. The binding box defines the space through which the 
centre of the defined ligand will be allowed to move during docking calculations. It 
provides a measure of the effective size of the search space. The only requirement on 
the enclosing box is that it be large enough to contain all ligand atoms, even when the 
ligand centre is placed at an edge or vertex of the binding box. Grid files were 
generated using the co-crystallized ligand at the centre of the two boxes.  
Components of Glide Score of Docking (Extra-Precision Mode) 
Component Description 
VdW Van der Waals energy is calculated with reduced net ionic charges on 
groups with formal charges, such as metals, carboxylates, and 
guanidiniums. 
Coul Coulomb energy is calculated with reduced net ionic charges on groups 
with formal charges, such as metals, carboxylates, and guanidiniums. 
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Lipo Lipophilic contact term. Rewards favourable hydrophobic interactions. 
HBond Hydrogen-bonding term is separated into differently weighted 
components that depend on whether the donor and acceptor are neutral, 
one is neutral and the other is charged, or both are charged. 
Metal Metal-binding term used only for the interactions with anionic acceptor 
atoms is included. If the net metal charge in the apo protein is positive, the 
preference for anionic ligands is included; if the net charge is zero, the 
preference is suppressed. 
BuryP Penalty for buried polar groups. 
RotB Penalty for freezing rotatable bonds. 
Site Polar interactions in the active site. Polar but non-hydrogen-bonding 
atoms in a hydrophobic region are rewarded. 
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4.5.4. SCREENING OF CARDIO PROTECTIVE ACTIVITY 102 
Rats were treated with different doses of Methanol extract of Triumfetta 
Rhomboidea (TRM) orally using an intra-gastric tube daily for 14 days. On 14th day, 
myocardial injury was induced in experimental rats by injection of ISO (200 mg kg-1, 
s.c.) twice at an interval of 24 h (i.e., on 14th and 15th day of extract treatment) while 
normal control and Isoproterenol (ISO) treated rats were given an equivalent volume of 
the vehicle. 
Treatment protocol 
The experimental rats were divided into four groups of 6 animals each and 
treated as follows: 
Group 1: Normal Control Rats received single daily dose of 5 % Tween 80 (5 ml/Kg; 
po) 
Group 2: Rats treated with 5 % tween 80 (5 ml/Kg; po) and ISO (200 mg kg/day for 2 
days, s.c.) 
Group 3: Rats pretreated with TRM (100 mg/ kg/ day, p.o.) and then ISO (200 mg kg-
1day-1; for 2 days, s.c.) 
Group 4: Rats pretreated with TRM (200 mg/ kg/ day, p.o.) and then ISO (200 mg kg-
1day-1; for 2 days, s.c.) 
Biochemical analysis: 
At the end of experimental period (after 24hr of second ISO injection or 16th day 
of extract/vehicle treatment) the rats were anaesthetized with light anaesthetic ether. 
Blood was collected from retro-orbital puncture, serum was separated and used for 
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estimation of marker enzymes. The activities of Aspartate Aminotransferase (AST) and 
Alanine Aminotransferase (ALT)6 in serum were determined spectrophotometrically 
and the absorbance was measured at 520 nm and enzyme activity was expressed as U 
L−1.The Lactate Dehydrogenase5 (LDH) activity in serum was assayed and the 
absorbance was measured 520 nm and the enzyme activity was expressed as U L−1.The 
Creatine Phosphokinase (CPK)4 activity in serum was determined and the absorbance 
was measured at 640 nm and the enzyme activity was expressed as IU L−1. 
4.5.5. IN VIVO ANTI-SNAKE VENOM ACTIVITIY 103-105  
Snake venom 
Lyophilized snake venom of Naja Naja was obtained from Haffkine Institute, 
Parel, Mumbai, and were preserved at 2 to 8°C. The Naja naja snake venom was 
dissolved in normal saline (0.9% w/v NaCl), centrifuged and the supernatant was used 
whenever required. The venom concentration was expressed in terms of dry weight 
(mg/ml) of the stock venom. 
In vivo anti- snake venom activity 
Oral administration of extract 5 min prior to the injection of venom .Twenty four  
adult Swiss albino mice of both sexes were divided into four  groups of six mice each. 
The control group was injected with only venom (lethal dose 61mcg/20 g of the mice , 
i.p), while the  other groups were treated separately with venom, after 5 min of oral 
administration of anti snake  venom serum (10mg/kg) and methanolic extract of 
Triumfetta rhomboidae ( 100 and 200mg/kg)  respectively. The mice were observed for 
24 hours for the number of mice which were survived. 
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4.5.6.ANALGESIC ACTIVITY BY ACETIC ACID INDUCED WRITHING IN 
MICE 106-107 
The analgesic activity of the samples was evaluated using acetic acid induced 
writhing method in mice. In this method, acetic acid is administered intraperitoneally to 
the experimental animals to induce pain sensation. As a positive control, any NSAIDS 
drug can be used. In the present study Diclofenac sodium was used to serve the purpose. 
Methanol extracts of Triumfetta rhomboidae were administered orally in two different 
doses (100 and 200 mg/kg body weight) to the Swiss Albino mice after an overnight 
fast. Test samples and vehicle were administered orally 30 minutes prior to 
intraperitoneal administration of 0.7% v/v acetic acid solution (0.1ml/10g) but 
Diclofenac sodium was administered 15 minutes prior to acetic acid injection. Then the 
animals were placed on an observation table. Each mouse of all groups were observed 
individually for counting the  number of writhing they made in 15 minutes commencing 
just 5 minutes after the  intraperitoneal administration of acetic acid solution. Full 
writhing was not always accomplished by the animal, because sometimes the animals 
started to give writhing but they did not complete it. This incomplete writhing was 
considered as half-writhing. Accordingly, two half-writhing were taken as one full 
writhing. The number of writhes in each treated group was compared to that of a control 
group while Diclofenac sodium (5 mg/kg) was used as a reference standard (positive 
control). 
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4.5.7.CARRAGEENAN INDUCED PAW EDEMA METHOD 108-110 
Acute anti-inflammatory activity was evaluated by carrageenan–induced rat paw 
edemas as described by Turner et al. Wistar albino rats were divided into 4 groups 
(n=6). Acute inflammation was produced by injecting 0.1 mL of 1% carrageenan into 
sub- plantar surface of rat hind paw. The control group I received Tween 80 (0.5%) 
0.1mL.The test groups  200 mg/kg methanol extracts of Triumfetta rhomboidae by oral 
route. The standard group received the drug diclofenac 40 mg/kg by oral route. All the 
suspensions were administered 30 minutes before carrageenan injection (0.1mL of 1%). 
The paw volume, up to the tibiotarsal articulation, was measured using a 
plethysmometer at 0, 1, 2, 3 and 6 hrs. 
4.5.8.WOUND HEALING ACTIVITY 111-112 
Excision wound model  
The groups were: 
Group 1: Control (treated with Simple ointment base (SOB))  
Group 2: Standard group treated with povidone iodine ointment  
Group 3: Treated with 100mg/kg of TRM 
Group 4: Treated with 200mg/kg of TRM 
Group 5: Treated with 10mg/kg of TRF 
Group 6: Treated with 20mg/kg of TRF  
The animals in each group were anaesthetized by the open mask method with 
anesthetic ether. Depilations of the rats were done on the dorsal side. The excision 
wound was inflicted by cutting away a 100 mm2 full thickness of skin from 
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predetermined shaved area Excision wound was left undressed. Topical application of 
the drugs to the divided group's viz. SOB, Reference Standard (Povidone Iodine 
ointment), respectively, were done until the wound heals completely. Wound 
contraction  was monitored. 
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5. RESULTS AND ANALYSIS 
5.1. EXTRACTION 
 The percentage yield of successive extractive values for leaves of Triumfetta  
Rhomboidea  is tabulated in Table 1 
Table 1 
The percentage yield of successive extracts of the leaves of Triumfetta Rhomboidea 
    
  S.No 
 
 Name of the 
Extract 
 
Colour of the extract 
 
Physical nature 
 
Percentage 
yield (w/w) 
1.   
       n-Hexane 
 
Green/Sticky mass 
 
Waxy Semisolid 
 
1.9 
2.   
Chloroform 
 
Green/Sticky mass 
 
Semisolid 
 
2.1 
3.   
Ethyl Acetate 
 
Brownish green solid 
 
Solid 
 
3.3 
4.   
Methanol 
 
Brownish green solid 
 
Solid 
 
7.7 
 
 
In the phytochemical analysis different polarity of phytoconstituents were sorted 
out from the powdered leaves of Triumfetta rhomboidea by using solvents like n-
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hexane, chloroform, ethyl acetate and methanol by successive extraction using soxhlet 
apparatus. Successive extractive values revealed the solubility and polarity particulars of 
the metabolites in the plant.  Methanolic extract showed high extractive yield of 7.7% 
w/w when compared to other extract of Triumfetta rhomboidea  
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5.2. PHYTOCHEMICAL EVALUATION 
Qualitative chemical analysis of phytoconstituents of the leaf extracts of 
Triumfetta rhomboidea tabulated in Table 2 
Table 2 
 Phytochemical screening of Triumfetta rhomboidea 
Note: + ve indicates positive result, whereas – ve indicates negative result 
  S.NO     TEST 
   n-Hexane  Chloroform Ethyl acetate  Methanol 
1.  Alkaloids  - - - + 
2.  Carbohydrate  - - + + 
3.  Glycosides  - - + + 
4.  Phytosterol - - - - 
5.  Fixed oils and Fats - - - - 
6.  Tannins  - - - - 
7.  Phenols  - - - + 
8.   Proteins  - - + + 
9.  Gums and Mucilages - - - - 
10.  Flavonoids  - - - + 
11.  Terpenoids  - - + + 
12.   Steroids  + + - - 
13.  Saponins - - + + 
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Qualitative preliminary phytochemical analysis of Triumfetta rhomboidea was 
performed initially with different chemical reagents to detect the nature of 
phytoconstituents and their presence in each extract. n-Hexane and chloroform extracts 
showed the presence of steroids. Ethyl acetate extract was found to contain terpenoids, 
glycosides, carbohydrates, proteins and saponins. Methanolic extract showed the 
presence of Alkaloids, terpenoids, carbohydrates, flavonoids, phenols, saponins, proteins 
and glycosides. 
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5.3. INVITRO FREE RADICAL SCAVENGING ACTIVITY 
The free radical scavenging activity of various extracts of Triumfetta 
Rhomboidea were detected. The methanol extract of Triumfetta Rhomboidea showed 
the dose dependent free radical scavenging activity in all in vitro assay models. Free 
radical scavenging activity of various extract of Triumfetta Rhomboidea was tabulated 
in table 3 and Figure 5 
Table 3 
Free radical scavenging activity of various extracts of Triumfetta Rhomboidea 
 
S. No 
 
Name of the 
Extract 
 
Concentration 
Mcg/ml 
Scavenging activity (%) 
DPPH Superoxide 
Radicals 
Nitric oxide 
Radicals 
1 n-Hexane 50 13.14±0.12 25.18±0.15 09.14±0.21 
2 n-Hexane 100 28.11±0.31 33.01±0.23 14.12±0.13 
3 Chloroform 50 31.14±0.14 19.12±0.24 19.23±0.26 
4 Chloroform 100 38.32±0.28 28.21±0.14 21.12±0.09 
5 Ethyl Acetate 50 26.04±0.22 28.12±0.14 16.12±0.15 
6 Ethyl Acetate 100 41.31±0.22 33.13±0.18 27.12±0.08 
7 Methanol 50 64.43±0.24 51.18±0.27 48.12±0.19 
8 Methanol 100 85.69±0.21 71.33±0.21 55.09±0.12 
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Figure 5: Free radical scavenging activity of various extracts of Triumfetta 
Rhomboidea 
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5.4. ACUTE TOXICITY OF TRIUMFETTA RHOMBOIDEA 
Table 4 
       Acute toxicity of  methanol extract of Triumfetta Rhomboidea 
S.No Dose 
(mg/kg/b.wt) 
 
Sex 
No of rats 
per dose 
Weight of 
rat 
( gm) 
Symptoms 
of toxicity 
    1 0 Male/ Female 6 150 Nil 
           2 5 Male/ Female 6 150 Nil 
            3 50 Male/ Female 6 150 Nil 
           4 300 Male/ Female 6 150 Nil 
           5 2000 Male/ Female 6 150 Nil 
Table 5 
Behavioural Responses of Acute toxicity of Triumfetta Rhomboidea 
S.No PARAMETERS OBSERVATION 
1.  Locomotor activity Normal 
2.  Gait Normal 
3.  Eyelid closure Normal 
4.  Effect of Auditory Stimulus Normal 
5.  Effect of tactile stimulus Normal 
6.  Abnormal secretion Normal 
7.  Alertness Normal 
8.  Body position Normal 
9.  Lighting reflex Normal 
10.  Lacrimation Normal 
11.  Urination/Defecation Normal 
12.  Piloerection Normal 
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5.5 PHARMACOLOGICAL SCREENING OF 7,12  DIMETHYL 
BENZ (a) ANTHRACENE INDUCED BREAST CANCER 
Table 6 
Incidence of mammary tumor in control and experimental rats in each group 
Groups Treatment Tumour 
incidence 
Total no of 
Tumours 
Tumour 
Volume 
I Control 0 0 0 
II DMBA  100% 10/10 15.68±1.2 
III DMBA + TRM (100mg/kg) 60% 06/10 2.14±0.12 
IV DMBA+TRM (200mg/kg) 30% 03/10 1.09±0.07 
V STD Tamoxifen 5mg/kg 30% 03/10 1.09±0.06 
 
Figure 6 
Tumour Incidence 
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Figure 7 
Total Number of Tumours 
 
Figure 8 
Tumour Volume  
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Table 7 
Effect  of plasma 17-β estradiol (E2) in control and experimental rats in each group 
 
Figure 9 
Effect  of plasma 17-β estradiol (E2) in control and experimental rats in each group 
 
 
 
Groups 17-β estradiol (pg/ml) 
Control 45.1±0.12 
DMBA 58.3±0.34 
DMBA+TRM(100mg/kg) 51.1±0.16 
DMBA+TRM(200mg/kg) 48.2±0.21 
 STD Tamoxifen (5mg/kg)                     47.1±0.25 
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Table 8 
Effect  of plasma TBARS and antioxidants in control and experimental rats in each 
groups 
 
Figure 10 
Effect  of plasma  TBARS,SOD and CAT  in control and experimental rats in each 
groups 
 
Groups TBARS 
(nmols/ml) 
SOD 
(U/mL) 
CAT 
(U/mL) 
GPx 
(U/mL) 
GSH 
(mg/dl) 
Control 1.84±0.12 2.89±0.01 1.59±0.11 154±0.09 31±0.12 
DMBA 3.45±0.21 1.73±0.05 1.09±0.24 109±0.04 19±0.16 
DMBA+TRM(100mg/kg) 2.59±0.09 2.31±0.09 1.21±0.32 139±0.07 24±0.09 
DMBA+TRM(200mg/kg) 1.34±0.11 2.74±0.12 1.45±0.19 146±0.03 29±0.20 
 STD Tamoxifen 
(5mg/kg) 
1.64±0.12 2.84±0.10 1.55±0.25 148±0.02 29±0.11 
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Figure 11 
 Effect  of plasma  GPx and GSH  in control and experimental rats in each groups 
 
Table 9 
Effect of mammary tissues TBARS and antioxidants in control and experimental 
rats in each group 
 
Groups TBARS 
(nmols/100g 
of tissue) 
SOD 
(U/mg of 
protein) 
CAT 
(U/mg of 
protein) 
GPx 
(U/mg 
of 
protein) 
GSH 
(mg/100mg 
of tissue) 
Control 0.74±0.11 12.69±0.21 41.59±0.10 18±0.19     08±0.32 
DMBA 1.15±0.31 07.30±0.05 28.09±0.24 29±0.08 13±0.46 
DMBA+TRM(100mg/kg) 0.99±0.19 10.31±0.19 35.01±0.12 21±0.17 11±0.69 
DMBA+TRM(200mg/kg) 0.78±0.12 12.74±0.20 39.25±0.14 19±0.13 09±0.42 
STD Tamoxifen( 5mg/kg) 0.77±0.14 12.64±0.10 40.15±0.12 18±0.17 08±0.52 
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Figure 12 
Effect of mammary tissues SOD,CAT,GPx and GSH in control and experimental 
rats 
          
 
Figure 13 
Effect of mammary tissues TBARS in control and experimental rats 
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HISTOPATHOLOGY 
 
                                        Fig 14 : Control Rat shows normal ductal epithelium 
 
Fig 15: DMBA induced rats showing ductal carcinoma and abnormal cellular 
proliferation 
 
Fig:16  DMBA+TRM(200mg/kg) rats showing ductal dysplasia 
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FIGURE  17 & 18 
The gross appearance of the mammary adenocarcinoma in DMBA( Figure 17)  and 
DMBA+ TRM (200mg/kg) ( Figure 18) treated female Sprague-Dawley rats. 
 
              
 
                                FIGURE  17                                                 FIGURE 18  
Table 6  shows the incidence of mammary tumors in DMBA, DMBA+TRM 100mg/kg 
DMBA+TRM 200mg/kg and Standard Tamoxifen treated rats. The present study 
observed 100% tumor incidence in rats treated with DMBA alone. The tumors were 
histopathologically confirmed as moderately and poorly differentiated adenocarcinoma. 
Oral administration of TRM 100mg/kg, 200mg/kg  and Tamoxifen  to DMBA-treated 
rats reduced the tumor incidence (40% , 70% and 70%, respectively) and tumors in this 
group (60% , 30% and 30%) (Figure 6) were histopathologically confirmed as well-
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differentiated adenocarcinoma. The size of the tumor and tumor volume observed in 
DMBA+  200mg/kg  and Tamoxifen treated rats   were very small as compared to rats 
treated with DMBA alone ( Figures 7&8) . Figure 17 and 18  show the gross 
appearance of mammary tumors  in DMBA treated and DMBA +TRM 200mg/kg 
treated rats  and  (Figures 14-16 ) show histological features in  Control ,DMBA, and 
DMBA+200mg/kg  treated rats. 
Control Rat shows normal ductal epithelium( Figure 14)  DMBA alone treated  
rats showing ductal carcinoma and abnormal cellular proliferation(Figure 15) TRM 
200mg/kg treated rats showed  ductal dysplasia(Figure 16 ) 
The level of plasma E2 was significantly increased in DMBA treated rats as 
compared to control rats (Table 7 & Figure 9 ). Oral administration of TRM 200mg/kg  
to DMBA-treated rats as well as control rats significantly (p<0.05) decreased the level 
of E2 which is comparable with standard. 
The levels of TBARS were significantly increased whereas GSH content and 
activities of SOD, CAT and Gpx in plasma were decreased in DMBA treated rats as 
compared to control rats (Table 8). Oral administration of 200mg/kg of TRM to DMBA-
treated rats significantly (p<0.05) decreased the levels of TBARS and improved the 
levels of GSH and activities of SOD, CAT and GPx.  The activity of 200mg/kg is equal 
to stanadard drug ( Table 8  and  Figures 10 & 11 )  
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The levels of TBARS, GSH and activity of GPx were increased whereas the 
activities of SOD and CAT were decreased in the tumor tissues as compared to normal 
tissues of control rats (Table 9). Oral administration of 200mg/kg of TRM to DMBA-
treated rats significantly (p<0.05) restored the status to near normal which is comparable 
with stamdard..( Table 9 and Figures 12 & 13 ) 
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5.6. EAC INDUCED ASCITES TUMOR MODEL SYSTEM 
Table 10 
Effect of TRM treatment on average life span of ascites tumour bearing mice 
Groups Treatment Mean survival days % ILS 
I Control 19.28±1.79 - 
II Standard( Cyclophosphamide) 27.42±0.97 42.22 
III TRM   ( 100mg/kg) 22.14±1.06 14.83 
IV TRM  (200mg/kg) 24.5±1.64 27.04 
  
  
 
Figure 19: Mean Survival Days 
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Figure 20 : Percentage increase in life span (% ILS) 
     
 
Effect of   TRM treatment on average life span of ascites tumour bearing mice 
The animals of the tumor control group inoculated with EAC cells survived for a 
period of 19.28± 1.79 days. The animals treated with cyclophosphamide survived for 
27.42± 0.97days. The TRM at 100 mg/kg body weight slightly increased the average life 
span of animals by 22.14±1.06 days.  But treatment at 200 mg/kg body weight was 
found to be more inhibiting the proliferation of EAC cells with the percentage increase 
in life span by 27.04 % and the average life span is 24.5±1.64 days  However, in 
cyclophosphamide treated mice (10 mg/kg), the percentage increase in life span was 
found to be the highest (42.22 %) ( Table 10 and Figures 19 & 20) 
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5.7. DLA INDUCED SOLID TUMOR MODEL SYSTEM 
Table 11 
Effect of   TRM treatment on average solid tumour volume 
 
Groups 
Tumor volume on 30 th 
day (cm3) % Inhibition 
Control 1.639±0.125 - 
Standard 0.412±.006 74.86% 
TRM( 100mg/kg)            0.823±0.085 49.78% 
TRM( 200mg/kg) 0.564±0.025 65.58% 
 
 
 
 
Figure 21 
 Tumour volume on 30th day 
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Figure 22   
Percentage Inhibition 
 
 
 
Effect of TRM treatment on average solid tumour volume 
The animals injected with DLA cell lines alone showed marked increase in 
tumor volume on the 30th day of inoculation in control group. The tumor volume in the 
mice treated with TRM extract at a dose  of 200 mg/kg b.wt on the 30th day of 
inoculation decreased significantly by 65.58%. The tumor volume had decreased by 
74.83 % in cyclophosphamide (10mg/kg) treated group.  TRM 200mg/kg has produced 
excellent activity equal to standard group. ( Table 11 and Figures 21 & 22 ) 
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5.8. DOCKING STUDIES FOR BREAST CANCER 
Docking studies were performed to identify the interactions of the compounds 
with breast cancer target receptors (BRCA1) being retrieved from the Protein Data Bank 
(id 4Y2G), using MVD (version 2013.6.0.1, installed on an Intel Centrino Machine 
(Intel Corporation, Santa Clara, CA, USA), probably the most accurate predictive tool of 
binding geometry, today.   
All the ligand structures were constructed using Chem 3D ultra 8.0 software, and 
then these structures were energetically minimized by using MOPAC (semi-empirical 
quantum mechanics), Jop Type with 100 iterations and minimum RMS gradient of 0.01, 
and saved as MDL mol format (.mol).  
The pre downloaded pdb structure of protein was imported to the workspace. 
Unwanted water molecules, cofactors, constraints and other ligands were removed.  
To obtain better potential binding sites in the protein, a maximum of five cavities 
were detected using parameters such as molecular surface (expanded Vander Waals), 
maximum number of cavities (n = 5), minimum cavity volume (10), maximum cavity 
volume (10000), probe size (1.20), maximum number of ray checks (n = 16), minimum 
number of ray hits (n = 12), and grid resolution (0.30).  The chosen cavity was further 
refined using side-chain minimization by selecting the add-visible option at a maximum 
of steps per residue (10000) and a maximum of global steps (10000). The setup for side-
chain flexibility by selection of the add-visible option, the setting for the selected 
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flexible side chain residues of maximum 15 during the docking option, and other 
parameters, all were kept in default.  
All docking calculations were carried out using the grid-based Mol Dock score 
(GRID) function with a grid resolution of 0.30 A˚. The binding site on the receptor was 
defined as extending in X=2.89, Y=66.53, and Z=67.62 directions around the Dock 
molecule with a radius of approximately 15.00 A˚. The Mol Dock optimization search 
algorithm with a maximum of ten runs was used through the calculations, with all other 
parameters kept as defaults. One pose per run was retained based on root mean square 
division clustering using a heavy atom threshold set at 1.0 A˚ and an energy penalty of 
100. All the poses were examined manually and the best poses were retained. 
 
Fig:23 Binding interaction of Friedelin with BRCA 1 protein (4Y2G) 
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Fig:24 Binding interaction of Friedelinol with BRCA 1 protein (4Y2G) 
 
Fig:25  Binding interaction of Co-crystalized ligand with BRCA 1 protein (4Y2G) 
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Fig:26  Binding mode of Friedelin and Friedelinol oh the gorge of BRCA 1 protein 
(4Y2G) 
Table:12 
Docking results of the compounds with BRCA1 protein (4Y2G) 
Name MolDock Score Rerank Score HBond 
Co-crystalized ligand -102.086 -40.001 -0.758 
Friedelin -127.902 -29.632 -2.497 
Friedelinol -130.267 -39.505 -0.752 
 
Name Interaction with residue 
Co-crystalized ligand Leu 1701, Asn 1774, Arg 1699, Glu 1698, Met 1775, Phe 1704 
Friedelin Arg 1699, Leu 1701, Asn 1774 
Friedelinol Ser 1655, Thr 1700, Leu 1701, Met 1775, Leu 1839, Arg 1699 
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The newly designed molecules were interacting with the target protein. The 
MolDock score of the test compounds is comparatively lower, that means the drug-
receptor complex is having better binding interaction (the negative values indicating the 
lower energy conformations). 
Between the two compounds, Friedelinol is having the better interaction values 
due to H-bond formed between the receptor residue (Ser 1655) and compound. Apart 
from that, the newly docked compounds were interacting with the native binding site of 
the receptor consisting of residues Arg 1699, Ser 1655, Leu 1701 and Asn 1774. The 
newly docked polycyclic natural compounds were able to bind with the BRCA1 receptor 
with more binding interactions (vander wall and steric interactions) than the native 
ligand (TYR-SER-ARG-SEP-PRO-THR-PHE) present in the crystalized structure of the 
protein. Results are presented in  Table 12 and Figures 23-26. 
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5.9. SCREENING OF CARDIO PROTECTIVE ACTIVITY 
Table 13 
Effect of Triumfetta rhomboidea on different biochemical parameters in 
Isoproterenol induced myocardial infarction in rats. 
Groups Treatment Aspartate 
amino 
transferase 
 
(AST) 
 
Alanine 
amino 
transferase 
 
(ALT) 
 
Lactate 
dehydrogenase 
(LDH) 
 
Creatine 
Phosphokinase 
(CPK) 
 
I Control 100.33±3.16 65.42±2.16 324±16 260.07±2.45 
II ISO 200mg/kg 207.01±4.05 180.18±3.03 643.12±3.1 324.57±2.08 
III ISO+TRM 
(100mg/kg) 
165.17±3.63  111.83±3.32 396.18±40 304.05±2.14 
IV ISO+TRM 
(200mg/kg) 
115.12±2.02 89.12±0.03 342.13±1.1 281.37±1.08 
Values are mean ± sem of 6 animals in each groups  Group II compared with group I. Group III-IV  
is compared with Group II and I  (ONE WAY ANOVA) P<0.001 
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Figure 27 
Effect of Triumfetta rhomboidea on different biochemical parameters in 
Isoproterenol induced myocardial infarction in rats. 
 
 
 
Effect of TRM on Isoproterenol induced myocardial infarction in rats 
The prior administration of TRM  (200 mg /kg) showed significant reduction in 
ISO induced elevated serum marker enzymes and At a dose of 100mg/kg the effect is 
only marginal but 200mg/kg  effectively prevented Isoproterenol induced cardiac 
damage (Table 13 and Figure 27) 
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5.10. IN VIVO ANTI-SNAKE VENOM ACTIVITIY 
 Table 14: In vivo Anti-snake venom activity of the methanolic extract of the leaves 
of TRM 
 
GROUPS Treatment No of animals 
Survived                
% Survival 
I Control 01 16.66 
II Snake Venom Antiserum 06 100 
III TRM 100 mg/kg 03 50 
VII TRM 200mg/kg 05 83.33 
Values are mean ± sem of 6 animals in each groups  Group II compared with group I. Group III-IV  
is compared with Group II and I  (ONE WAY ANOVA) 
 Figure 28 : No of Animals Survived in control and extract treated groups 
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Figure 29 : % Survival in  control and extract treated groups 
          
 
 
In vivo Anti-snake venom activity of the methanolic extract of the leaves of 
Triumfetta rhomboidea 
In-vivo anti-snake venom activity of the methanolic extract  of Triumfetta 
rhomboidea was studied at dose level of  100 and 200 mg/kg body weight respectively. 
In control group, which was treated with only venom (61mcg/20g) only one mice were 
survived. Mice treated with 100 mg/kg of methanol  extract  of TRM recorded 50% 
survival,  200mg/kg showed 83.33%, and the standard showed 100% survival which is  
shown in the Table 14 and Figures 28 &29. 
 
 
 
CHEMOPREVENTIVE ACTIVITY OF SOME MEDICINAL PLANT ON 7,12- DMBA 
INDUCED BREAST CANCER 
 
   Mr R.SURESH                               PH.D THESIS – JUNE 2017                                 Page 96 
 
5.11. ANALGESIC ACTIVITY BY ACETIC ACID INDUCED WRITHING IN 
MICE 
Table 15 
Analgesic activity of the methanolic extract of the leaves of  Triumfetta rhomboidea  
by acetic acid induced writhing in mice 
Values are mean ± sem of 6 animals in each groups . Group II compared with group I. Group III-IV  
is compared with Group II and I  (ONE WAY ANOVA) P<0.001 
 
 
 
 
 
 
 
 
 
GROUPS DRUG TREATMENT AND DOSE NO OF 
WRITHINGS 
% 
INHIIIBITION 
I Control  (5ml/kg) 59.32 ±1.69 ------ 
II Diclofenac  ( 5 mg/kg) 24.52 ±0.45 58.66 
III TRM 100mg/kg 32.45 ±0.85 45.32 
IV TRM 200mg/kg 28.76 ±0.72 51.51 
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Figure 30 
Analgesic activity of the leaves of TRM by acetic acid writhing in mice. 
 
5.11 Analgesic activity of the methanolic extract of the leaves of  Triumfetta 
rhomboidea by acetic acid induced writhing in mice 
The effect of TRM produced significant reduction in the number of writhing in 
mice at 200 mg/kg oral dose, the percent reduction of writhing  of TRM was 51.51 %, as 
compared to the control group, whereas the standard drug Diclofenac (5 mg/kg p.o.) 
showed a reduction of 58.66%.. ( Table 15 and Figure 30) 
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5.12. CARRAGEENAN INDUCED PAW EDEMA METHOD 
Table 16 
Anti inflammatory activity of  Triumfetta rhomboidea on Carageenan induced paw 
edema  
Groups 
        
 Treatment and Dose Paw volume 
Mean ± SEM 
                  Paw volume in ml Mean ± SEM 
1 hour 2 hour 3 hour 6 hour 
 I Control 0.5% tween 80 
(0.1ml) 
0.25±0.03 0.34±0.01 0.48±0.02 0.56±0.02 0.78±0.03 
 II TRM   100mg/kg  0.19±0.03 0.31±0.02 0.35±0,01 0.48±0.03 0.29±0.02 
III TRM 200mg/kg  0.24±0.01 0.34±0.01 0.42±0.02 0.45±0.02 0.26±0.01 
IV Diclofenac   sodium  
40mg/kg 
0.20±0.01 0.26±0.01 0.31±0.01 0.36±0.05 0.23±0.01 
Values are expressed as Mean ±Sem for 6 animals in each group .]  Group II and III compared with Group I 
and   Group IV.(ONE WAY ANOVA) P<0.001 
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Figure 31 
Anti inflammatory activity of  Triumfetta rhomboidea on Carageenan induced paw 
edema in rats  
 
 
Anti inflammatory activity of  Triumfetta rhomboidea  on carageenan induced paw 
edema in rats  
The carrageenan induced edema develops by release of inflammatory mediators such as 
histamine, kinin, bradykinin, and prostaglandins .As shown in Table 16   Diclofenac 
sodium showed significant inhibition of rat paw edema at 6 hr. The extracts of  TRM 
100mg/kg and 200mg/kg reduced the inflammation of rat paw edema at 6 hr.  At a dose 
of 200mg/kg effectively reduced inflammation which was comparable with standard( 
Figure 31) 
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5.13.  WOUND HEALING ACTIVITY 
Table 17 
Effect of of  Triumfetta rhomboidea treatment on wound contraction (wound 
excision model) 
Groups and Treatment 0 Day 4th Day 8th Day 12th Day 16th Day 
Simple ointment base 619±1.02 574±3.12 423±3.09 292±1.65 94±1.33 
Povidone iodine ointment 560±2.18 234±2.28 74±2.97 21±2.71 07±2.12 
2% w/v of TRM 582±1.07 284±0.98 91±1.17 36±1.56 11±1.09 
Figure 32 
Effect of of  Triumfetta rhomboidea treatment on wound contraction (wound 
excision model) 
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Figure-33 
Effect of of  Triumfetta rhomboidea  treatment on wound contraction (wound 
excision model) 
              CONTROL                                      STD                                 2% w/v of TRM 
 
                                    
          0 day 
 
 
                               
         8th day 
 
 
                            
16th day 
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2% w/v of TRM on 16th day (11±1.09) has a positive influence on  wound 
contraction phase of wound healing which is comparable with std Povidone iodine 
ointment (07±2.12) . Results are presented in Table 17 and Figures 32 & 33. 
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5.14.CHARACTERIZATION OF EFFCTIVE FRACTION OBTAINED 
FROM TRIUMFETTA RHOMBOIDEA BASED ON INVITRO AND 
INVIVO PHARMACOLOGICAL ACTIVITY 
 
 
5.14.1.THIN LAYER CHROMATOGRAPHY 
Table 18 
The TLC studies of methanol extract of Triumfetta rhomboidea 
S.No Name of the Extract Solvent system No of spots Rf Values 
 
1 
 
Methanol ( TRM) Methanol : Ethyl acetate: Water 
(6:3:1) 
 
04 
0.20 
0.45 
0.52 
0.72 
 
5.14.2.HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY 
Table 19 
HPTLC fingerprint of methanol extract of Triumfetta rhomboidea  
S.No Name of the Extract Detection Wavelength No of spots Rf Values 
 
 
1 
 
 
 
 
Methanol ( TRM)  
  254nm 
 
 
 
 
 
 
10 
0.06 
0.15 
0.18 
0.24 
0.33 
0.39 
0.51 
0.58 
0.65 
0.71 
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Fig-34. HPTLC fingerprint of methanol extract of Triumfetta rhomboidea 
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5.15. ISOLATION OF COMPOUNDS FROM   TRIUMFETTA RHOMBOIDEA 
BY  COLUMN CHROMATOGRAPHY 
Table-20 
5.15.1.Column Eluted Fractions of  Triumfetta rhomboidea 
List of Column Eluted Fractions of Triumfetta rhomboidea 
Fraction 
No 
Column fractions eluted with following 
solvent 
Weight of sample Consistency  
and color 
1.  Ethyl acetate–hexane (3:2)- 0.176g Yellow crystal 
2.  Ethyl acetate–hexane (3:2) 0.216g White powder 
3.  Benzene–acetone–ethyl acetate (7:5:1) 1g Yellow  needles 
4.  Ethyl acetate–n-hexane(3:1) 0.074g Orange needles 
5.  Ethyl acetate–hexane (7:3.5) 0.143g yellow colour needle 
Characterization of Compound – I 
Yellow needles colour (1g) was obtained which is soluble in methanol and 
water, the melting point was found to be 210-215o C. The isolated compound answered 
the test for flavonoids. Spectral data of fraction 3 was depicted in the Figures 
35,36,37,38 
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Fig : 35  Infra red  Spectrum of compound I 
 
 
 
Table-21 Infra red  Spectral Data 
Wave Numbers (cm-1) Type 
3369 OH 
2930 CH3,CH2,CH 
1686 C=C 
1412 C-O 
1276 C-O 
1075 C-O 
913 C-O 
634 (CH) 
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Fig :36   1 H  Nuclear Magnetic Resonance spectral  data for Compound 1 
 
 
FIG : 37 13 C  Nuclear Magnetic Resonance spectral  data for Fraction 3 (TRM)  
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Table-22 
HNMR and 13 C  Nuclear Magnetic Resonance spectral  data for Fraction 3 (TRM) 
Atom Carbon, δ  , ppm Hydrogen, δ  , ppm 
1 73.41 3.36-4.04(m, 1H) 
2 73.62 3.36 – 4.04 (m, 1H) 
3 101.78 4.91 – 5.17 (m, 1H) 
4 64.36 3.36 – 4.04 (m, 2H) 
5 75.25 3.36 – 4.04 (m, 1H) 
6 71.82 3.36 – 4.04 (m, 1H) 
7 72.40 3.36 – 4.04 (m, 1H) 
8 76.46 3.36 – 4.04 (m, 1H) 
9 97.98 4.91 – 5.17 (m, 1H) 
10 71.62 3.36 – 4.04 (m, 1H) 
11 76.52 3.36 – 4.04 (m, 1H) 
12 61.35 3.36 – 4.04 (m, 2H) 
 
Fig 38 Mass spectrum for Fraction 3 (TRM) 
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Properties of the Isolated compound 
Name    - Rhamnetin-3-O- β-D-Galactosyl-4- O-β -D-galactopyranoside 
Molecular formula - C28H32O17 
Molecular weight -640 
Mass (m/z)  - 639( M )+ 
Colour   -Yellow needles 
Structure of the isolated compound 
 
Structure of the fraction 3 (TRM) 
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6. DISCUSSION 
Phytochemical evaluation 
Methanolic extract showed high extractive yield of 8.5 %w/w  when compared 
to other extracts of Triumfetta rhomboidea. Preliminary phytochemical analysis of 
Triumfetta rhomboidea was performed initially with different chemical reagents to 
detect the nature of phytoconstituents and their presence in each extract. Methanolic 
extract of Triumfetta rhomboidea  showed the presence of alkaloids, terpenoids, 
carbohydrates, flavonoids, phenols, saponins, proteins and glycosides.  
In Phytochemical evaluation various extracts were prepared and studied for 
qualitative chemical analysis such as TLC and HPTLC finger print analysis. Qualitative 
chromatographic analysis (TLC) was performed for the identification of different 
components in the extracts qualitatively. The HPTLC finger print of methanol extracts 
of these plants were also studied. HPTLC was scanned at 254nm with the best solvent to 
detect the maximum number of components and peak abundance qualitatively. HPTLC 
fingerprint is one of the versatile tools for qualitative and quantitative analysis of active 
constituents.  
Invitro free-radical scavenging activity 
The therapeutically active extract to carry out the pharmacological studies in 
animals was selected on the basis of in- vitro studies like in-vitro free radical scavenging 
activity and phytochemical analysis. Among the four extract the methanolic extract 
showed significant activity in both plants. The methanol extract of  Triumfetta 
rhomboidea  showed the dose dependent free radical scavenging activity in all in vitro 
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assay models. Hence it was selected for the screening of in-vivo pharmacological 
studies. Pharmacological activity dealt with the screening of acute toxicity study, 
Chemopreventive, Cardioprotective, Analgesic, Anti-inflammatory, Wound healing 
activity, Anti-tumor activity and Anti-snake venom activities of methanolic extract of 
the leaves of Triumfetta rhomboidea  . 
Acute toxicity study 
Acute toxicity studies performed on methanol extract of Triumfetta rhomboidea  
 (according to OECD guidelines 423). The methanolic extract of Triumfetta rhomboidea  
was found to be very safe up to 2000mg/kg body weight. All the animals were found to 
be normal and there were no gross behavioral changes till the end of the observation 
period. Hence from this 1/20th and 1/10th of MTD was selected and the effective doses 
were fixed as 100 and 200 mg/kg for the further pharmacological studies. 
Chemopreventive activity 
The present study observed 100% tumor incidence in rats treated with DMBA 
alone. The tumors were histopathologically confirmed as moderately and poorly 
differentiated adenocarcinoma. Oral administration of TRM 100mg/kg and 200mg/kg  
to DMBA-treated rats reduced the tumor incidence and  tumors in this group. 
Histopathologically control Rat shows normal ductal epithelium. DMBA alone treated  
rats showing ductal carcinoma and abnormal cellular proliferation and  TRM 200mg/kg 
treated rats showed  ductal dysplasia.The size of the tumor and tumor volume observed 
in DMBA+  200mg/kg treated rats   were very small as compared to rats treated with 
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DMBA alone .Oral administration of TRM 200mg/kg  to DMBA-treated rats as well as 
control rats significantly (p<0.05) decreased the level of E2.  
The levels of TBARS were significantly increased whereas GSH content and 
activities of SOD, CAT and Gpx in plasma were decreased in DMBA treated rats as 
compared to control rats Oral administration of 200mg/kg of TRM to DMBA-treated 
rats significantly (p<0.05) decreased the levels of TBARS and improved the levels of 
GSH and activities of SOD, CAT and GPx. The levels of TBARS, GSH and activity of 
GPx were increased whereas the activities of SOD and CAT were decreased in the 
tumor tissues as compared to normal tissues of control rats. Oral administration of 
200mg/kg of TRM to DMBA-treated rats significantly (p<0.05) restored the status to 
near normal. Based on the biochemical analysis and histopathology, administration of  
TRM prevented  the breast cancer caused by the chemotherapy agents. After analysis of 
the breast tissues  the results of this research concluded that the antioxidant properties of 
this plant and its potentiation effect contributed to the observed protection against breast 
cancer . 
  This herbal therapy has proved effective in reducing the toxic effects  of  breast 
cancer and  have shown that this herbal therapy help get relief from the breast cancer. 
Cardioprotective activity 
Isoproterenol (ISO) is well known cardiotoxic agent due to its ability to destruct 
myocardial cells. As a result, cytosolic enzymes such as Lactate Dehydrogenase (LDH), 
Transaminases (ALT and AST) and Creatine Phosphokinase (CPK) were released into 
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blood stream and serve as the diagnostic markers of myocardial tissue damage. The 
amount of these cellular enzymes present in blood reflects the alterations in plasma 
membrane integrity and/or permeability. In the present study, Isoproterenol treated rats 
showed significant elevation in the levels of these diagnostic marker enzymes (AST, 
ALT, LDH and CPK). Moreover, elevated levels of these enzymes are an indicator of 
the severity of ISO-induced myocardial membrane necrosis. The prior administration of  
TRM (200 mg /kg) showed significant reduction in ISO induced elevated serum marker 
enzymes. Higher dose of 200 mg/kg of methanol extract Triumfetta rhomboidea 
effectively prevented Isoproterenol induced cardiac damage.  
In the present study, I found  that Triumfetta rhomboidea leaves methanol extract 
protected myocardium from Isoproterenol-induced myocardial functional injury via 
normalization levels of diagnostic marker enzymes, suggesting the beneficial action of  
Triumfetta rhomboidea as a Cardioprotective agent. 
In-vivo anti snake venom activity 
The methanol extract was screened for in-vivo anti snake venom activity. The 
extract of Triumfetta rhomboidea at 200mg/kg increased the percentage survival which 
was comparable to that of  standard anti venom serum. It was observed that the survival 
of the mice increased progressively with increasing the dose of the extract in a dose 
dependant manner. α-Cobratoxin is a substance of the venom of Naja Naja. It is a 
nicotinic acetylcholine receptor (nAChR) antagonist which binds antagonistically and 
slowly reversible to muscle-type and neuronal type nAChRs. This bond will block the 
receptor’s ability to bind acetylcholine and thereby inhibits the ion flow through the 
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postsynaptic membrane, which will lead to paralysation.  The probable mechanism of 
preventing the neurotoxic effect by Triumfetta rhomboidea may be by interfering with 
the acetylcholine receptor sites by antagonizing the actions of the neurotoxic substances 
in the venom at the acetylcholine receptor sites.  
Analgesic activity  
Acetic acid causes inflammatory pain by inducing capillary permeability and 
liberating endogenous substances that excite pain nerve ending. Acetic acid is also 
known to increase PGE1 and PGE2 peripherally. NSAIDs can inhibit COX in peripheral 
tissues and therefore interfere with the mechanism of transduction of primary afferent 
nociceptors 
The effect of TRM produced significant reduction in the number of writhing in 
mice at 200 mg/kg oral dose, the percent reduction of writhing  of TRM was increased  
respectively, as compared to the control group.The mechanism of analgesic activity of 
TRM could be probably due to the blockade of the effect or the release of endogenous 
substances that excite pain nerve endings similar to that of Diclofenac. Thus, the 
reduction in the number of writhing indicates that Triumfetta rhomboidea might exert 
anti-nociceptive activity by inhibition of prostaglandin synthesis or action of 
prostaglandin. 
Wound healing activity 
Present study clearly demonstrated that methanol extracts Triumfetta 
rhomboidea possessed a definite pro healing action in normal healing as observed by 
significant increase in the rate of wound contraction. Wound contraction involves a 
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complex and superbly orchestrated interaction of cells, extracellular matrix and 
cytokines. In the present study extract treated wounds were found to contract much 
faster. Increased rate of wound contraction in extract treated wounds might be due to 
increase in transformation of fibroblast cells into myofibroblast cells. Equal proportion 
of topical application of methanol extracts of leaves of Triumfetta rhomboidea has a 
positive influence on  wound contraction phase of wound healing, has a beneficial in 
wound healing.  
Invivo Anti-tumour activity 
The cytotoxic effect of crude methanol  extracts of Triumfetta rhomboidea  on 
DLA and EAC cells  was evaluated .The maximum amount of inhibition is observed in 
200mg/kg of TRM. A dose  dependent activity was exhibited both by methanol extracts 
where both DLA  and EAC cells were sensitive to methanol extract.  Among the  
various groups  tested for anti-cancer activity, 200mg/kg exhibited very good  activity 
which was comparable with standard drug Cyclophosphamide . 
Docking Analysis 
In this study we have designed a set of 2 compounds of Triumfetta rhomboidea  
molecules and performed docking simulations in order to identify their binding affinity 
and binding  energy towards the BRCA 1 protein .To identify the molecular binding 
interactions of the analogs with the receptor, two ligands were  docked into the active 
binding site of the enzyme BRCA 1using Glide docking algorithm The newly designed 
molecules were interacting with the target protein. The MolDock score of the test 
compounds is comparatively lower, that means the drug-receptor complex is having 
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better binding interaction (the negative values indicating the lower energy 
conformations). 
Between the two compounds, Friedelinol is having the better interaction values 
due to H-bond formed between the receptor residue (Ser 1655) and compound. Apart 
from that, the newly docked compounds were interacting with the native binding site of 
the receptor consisting of residues Arg 1699, Ser 1655, Leu 1701 and Asn 1774. The 
newly docked polycyclic natural compounds were able to bind with the BRCA1 receptor 
with more binding interactions (vander wall and steric interactions) than the native 
ligand (TYR-SER-ARG-SEP-PRO-THR-PHE) present in the crystalized structure of the 
protein. 
The docking  study showed  that the  leaves of Triumfetta rhomboidea  is 
potential for the chemopreventive activity by inhibiting  BRCA1 protein. Friedelinol has 
shown excellent chemopreventive activity compared to  Friedelin. 
Isolation and Characterization  
 The structure of the  compound isolated from Triumfetta rhomboidea  was 
analysed by spectroscopic techniques and the melting point of the compound was found 
to be 210-2150C. It answered the test for flavanoids. It had IR absorptions at 
3369(hydroxyl), 2930 (C-H stretching of alkanes), 1412,1276, 1075 and 913 (C-O 
vibrations of alcohols) and 634 (C-H bending vibration of alkanes The 1H NMR 
spectrum showed the presence of 14 protons on saturated carbon atoms. The protons are 
multiplet with the value of 3.36- 4.04 (M,H) in up field and the value at 4.19- 5.17 
(M,H) showed the protons in the down field. The peak appeared in the range between 
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3.36-4.04 ppm corresponds to carbon connected to oxygen linkage. 1H and 13C NMR 
spectrum of the compound showed the peaks at 73.41, 73.62, 75.25, 71.82, 72.40, 76.46, 
71.62 and 76.52 indicated the carbon connected to oxygen linkage. Mass spectrum of 
the compound showed the molecular ion peak at m/z 639. From the spectral studies the 
possible structure of compound may be Rhamnetin-3-O-β-D-Galactosyl-4- O-β-D-
galactopyranoside.  
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7. SUMMARY AND CONCLUSION 
SUMMARY 
 
The thesis entitled “Chemo preventive activity of  Triumfetta rhomboidea   in 7, 
12 Dimethylbenz (A) Anthracene induced Breast cancer in Sprague –Dawley rat 
model.” deals with phytochemical and pharmacological investigation of traditionally 
used medicinal plants. A perusal of the literature revealed that only fragmentary 
information was available on these plant species regarding pharmacological activity by 
any other researchers. Plants are becoming potential source for phytoconstituents with 
varied pharmacological activities. Identification of such plants of potential use in 
medicine is of significance.  
Cells in humans and other organisms are constantly exposed to a variety of 
oxidizing agents, some of which are necessary for life. In the status of normal 
metabolism, levels of oxidants and antioxidants in humans are maintained in balance, 
which is important for sustaining optimal physiological conditions. Overproduction of 
oxidants in certain conditions can cause an imbalance, leading to oxidative damage to 
large biomolecules such as lipids, DNA, and proteins. Many synthetic drugs protect 
against oxidative damage but they have adverse side effects. Recently, there has been a 
considerable interest in finding natural antioxidants from plant materials to replace 
synthetic ones.  Natural antioxidant substances are presumed to be safe since they occur 
in plant foods, and are seen as more desirable than their synthetic counterparts. Data 
from both scientific  reports and laboratory studies show that plants contain a  large 
variety of substances called ‘‘plant chemicals’’ or  ‘‘phytochemicals’’ that possess 
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antioxidant activity Since, secondary metabolites are responsible for biological activity, 
this study would be the leading path way of information for selection of the extract for 
pharmacological activity and isolation of constituents responsible for the activity. 
The various pharmacological activities such as Cardioprotective, Analgesic, 
Antiinflammatory, Wound healing, Anti-tumor and Anti-snake venom activity were  
established by this test extract can be investigated further in future to get their 
meaningful extension in clinical use. The therapeutic activities were carried out 
scientifically and reported for the first time in this plant 
Methanol extracts of Triumfetta rhomboidea  was  selected for column 
chromatographic separation in an attempt to isolate the most effective fraction 
responsible for the therapeutic activity. The effective fraction of Triumfetta rhomboidea  
was selected based on the pharmacological activity and the structure of the compound 
was confirmed by IR, 1H NMR, 13C NMR and Mass spectral data. The compound was 
found to be Rhamnetin-3-O-β-D-Galactosyl-4- O-β-D-galactopyranoside and it was first 
time isolated from the leaves of Triumfetta rhomboidea .The interest in studying herbal 
products is further supported by the observations that many herbal extracts show 
superior effect when compared to single chemical constituents at the equivalent dose (or 
concentration). 
With the support of phytochemical studies and in-vitro pharmacological 
activities the methanolic extract was selected and subjected to in-vivo pharmacological 
studies.  
CHEMOPREVENTIVE ACTIVITY OF SOME MEDICINAL PLANT ON 7,12- DMBA 
INDUCED BREAST CANCER 
 
   Mr R.SURESH                               PH.D THESIS – JUNE 2017                                 Page 120 
 
 The dose level of 200mg/kg  showed promising  Chemopreventive activity 
against breast cancer. Which is equal to standard drug Tamoxifen. The in vitro free 
radical scavenging assays indicate that these  plant extracts  provided significant source 
of natural antioxidant which is mainly responsible for its anticancer activity 
Based on the biochemical analysis and histopathology, the plant Triumfetta 
rhomboidea  leaves prevented breast cancer  caused by the chemotherapy agents. After 
analysis of the breast tissue , the results of this research concluded that the antioxidant 
properties of this plant  contributed to the observed protection against breast cancer . 
The docking  study concluded  that the  leaves of Triumfetta rhomboidea  is 
potential for the breast cancer  by inhibiting   BRCA1  Receptor.  Friedelinol has shown 
excellent  activity against breast cancer.. 
CONCLUSION  
In my research I found the effective herbal  therapy for  breast cancer. Triumfetta 
rhomboidea leaves exhibited stongest chemopreventive activity especially for treating 
the  Breast cancer  
 
 
 
 
 
 
 
CHEMOPREVENTIVE ACTIVITY OF SOME MEDICINAL PLANT ON 7,12- DMBA 
INDUCED BREAST CANCER 
 
   Mr R.SURESH                               PH.D THESIS – JUNE 2017                                 Page 121 
 
8. IMPACT OF THE STUDY 
In my research I found the effective herbal  therapy for  breast cancer. Triumfetta 
rhomboidea leaves exhibited stongest chemopreventive activity especially for treating 
the Breast cancer. 
Future studies 
  Use of this herbal therapy  according to Indian  medicine concepts   has not been 
systematically explored to benefit modern pharmacotherapy.  The therapeutic effect 
must be carefully evaluated by a well-designed, randomized, double-blinded, placebo-
controlled clinical trial involving a significant number of subjects (i.e., with sufficient 
power).  , clinical trials following good clinical practice (GCP) should be implemented 
to demonstrate clinical efficacy of this plant in breast cancer. In future this effective  
herbal therapy of Triumfetta rhomboidea  must be evaluated clinically to benefit the 
patients suffering breast cancer. 
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